<SEC-DOCUMENT>0000950103-25-015127.txt : 20251121
<SEC-HEADER>0000950103-25-015127.hdr.sgml : 20251121
<ACCEPTANCE-DATETIME>20251121093917
ACCESSION NUMBER:		0000950103-25-015127
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251121
DATE AS OF CHANGE:		20251121

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251504888

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251504889

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237771_424b2-us25a0166d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">The information in this preliminary
pricing supplement is not complete and may be changed. A registration statement relating to these notes has been filed with the Securities
and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus
supplement and prospectus are not an offer to sell these notes, nor are they soliciting an offer to buy these notes, in any state where
the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">SUBJECT TO COMPLETION, DATED NOVEMBER
21, 2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Pricing Supplement No. 2025-USNCH29452 to Product Supplement No. EA-02-10
dated March 7, 2023,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Underlying Supplement No. 11 dated March 7, 2023, Prospectus Supplement
and Prospectus each dated March 7, 2023</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Filed Pursuant to Rule 424(b)(2)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Registration Statement Nos. 333-270327 and 333-270327-01</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Dated November<FONT STYLE="color: white">-----</FONT>, 2025</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Citigroup Global Markets Holdings Inc. $---- Trigger Callable Yield
Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Linked to the Least Performing of the Nasdaq-100 Index<SUP>&reg;</SUP>
and the Russell 2000<SUP>&reg;</SUP> Index Due On or About March 2, 2027</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>All payments due on the notes are fully and unconditionally guaranteed
by Citigroup Inc.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Investment Description</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Trigger Callable Yield Notes (the &ldquo;<B>notes</B>&rdquo;) are
unsecured, unsubordinated debt obligations of Citigroup Global Markets Holdings Inc. (the &ldquo;<B>issuer</B>&rdquo;), guaranteed by
Citigroup Inc. (the &ldquo;<B>guarantor</B>&rdquo;), linked to the <B>least performing</B> of the Nasdaq-100 Index<SUP>&reg;</SUP> and
the Russell 2000<SUP>&reg;</SUP> Index (each, an &ldquo;<B>underlying</B>&rdquo;).&nbsp;&nbsp;The notes will pay a coupon on each monthly
coupon payment date regardless of the performance of either underlying.&nbsp;&nbsp;Beginning approximately three months after issuance,
on any coupon payment date prior to the maturity date, the issuer may, in its sole discretion, call the notes in whole, but not in part,
and pay you the stated principal amount per note plus any coupon otherwise due on such coupon payment date and no further amounts will
be owed to you.&nbsp;&nbsp;If the notes have not previously been called by the issuer prior to maturity and the final underlying level
of the least performing underlying is greater than or equal to its downside threshold, you will receive the stated principal amount of
your notes at maturity plus any coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However, if the notes have not been called
prior to maturity and the final underlying level of the least performing underlying is less than its downside threshold, you will receive,
in addition to the final coupon, an amount that is less than the stated principal amount of your notes at maturity, resulting in a loss
that is proportionate to the decline in the closing level of the least performing underlying from the trade date to the final valuation
date, up to a 100% loss of your investment.&nbsp;&nbsp;The &ldquo;<B>final underlying level</B>&rdquo; for each underlying is the closing
level of such underlying on the final valuation date and the &ldquo;<B>least performing underlying</B>&rdquo; is the underlying with
the lowest underlying return as measured from the trade date to the final valuation date.&nbsp;&nbsp;<B>Investing in the notes involves
significant risks.&nbsp;&nbsp;You may lose a substantial portion or all of your initial investment if the notes are not called by the
issuer in its sole discretion on any coupon payment date prior to the maturity date and the final underlying level of the least performing
underlying is less than its downside threshold.&nbsp;&nbsp;The payment at maturity on the notes is based <U>solely</U> on the performance
of the least performing underlying.&nbsp;&nbsp;You will not benefit in any way from the performance of the better performing underlyings.&nbsp;&nbsp;You
will therefore be adversely affected if <U>either underlying</U> performs poorly, regardless of the performance of the other underlyings.&nbsp;&nbsp;You
will not receive dividends or other distributions paid on any stocks included in the underlyings or participate in any appreciation of
either underlying.&nbsp;&nbsp;The contingent repayment of the stated principal amount applies only if you hold the notes to maturity
or earlier call by the issuer.&nbsp;&nbsp;Any payment on the notes, including any repayment of the stated principal amount, is subject
to the creditworthiness of the issuer and the guarantor and is not, either directly or indirectly, an obligation of any third party.
If the issuer and the guarantor were to default on their payment obligations, you may not receive any amounts owed to you under the notes
and you could lose your entire investment.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 69%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Features</B></FONT></TD>
    <TD STYLE="width: 2%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 29%; background-color: #788D41; font-size: 12pt"><FONT STYLE="font-size: 10pt; color: white"><B>Key Dates<SUP>1</SUP></B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 69%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD STYLE="width: 96%"><FONT STYLE="font-size: 10pt"><B>Monthly Coupon</B> &mdash; We will pay you a coupon on each monthly coupon payment date regardless of the performance of either underlying unless the notes have been previously called.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Issuer Callable </B>&mdash; Beginning approximately three months after issuance, on any coupon payment date prior to the maturity date, the issuer may, in its sole discretion, call the notes in whole, but not in part, and pay you the stated principal amount per note plus any coupon otherwise due on such coupon payment date.&nbsp;&nbsp;If the notes are not called, investors may have full downside market exposure to the least performing underlying at maturity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Downside Exposure with Contingent Repayment of Principal at Maturity </B>&mdash; If the notes have not previously been called by the issuer prior to maturity and the final underlying level of the least performing underlying is greater than or equal to its downside threshold, you will receive the stated principal amount of your notes at maturity plus any coupon payment otherwise due on the maturity date.&nbsp;&nbsp;However, if the notes have not been called prior to maturity and the final underlying level of the least performing underlying is less than its downside threshold, you will receive, in addition to the final coupon, an amount that is less than the stated principal amount of your notes at maturity, resulting in a loss that is proportionate to the decline in the closing level of the least performing underlying from the trade date to the final valuation date, up to a 100% loss of your investment.&nbsp;&nbsp;<B>Any payment on the notes is subject to the creditworthiness of the issuer and guarantor. If the issuer and the guarantor were to default on their obligations, you might not receive any amounts owed to you under the notes and you could lose your entire investment.</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 29%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%"><FONT STYLE="font-size: 10pt">Trade date</FONT></TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-size: 10pt">November 25, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Settlement date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 28, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Coupon payment dates<SUP>2</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Monthly, beginning on December 30, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final valuation date<SUP>2</SUP></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">February 25, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Maturity date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">March 2, 2027</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><SUP>1</SUP></TD><TD>Expected</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><SUP>2</SUP></TD><TD>See page PS-4 for additional details.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>NOTICE TO INVESTORS: <FONT STYLE="text-transform: uppercase">The
notes are significantly riskier than conventional debt INSTRUMENTS. THE ISSUER IS NOT NECESSARILY OBLIGATED TO REPAY THE STATED PRINCIPAL
AMOUNT OF THE NOTES AT MATURITY, AND the notes CAN have downside MARKET risk SIMILAR TO the LEAST PERFORMING UNDERLYING.&nbsp;&nbsp;This
MARKET risk is in addition to the CREDIT risk INHERENT IN PURCHASING A DEBT OBLIGATION OF CITIGROUP GLOBAL MARKETS HOLDINGS INC. THAT
IS GUARANTEED BY CITIGROUP INC.&nbsp;&nbsp;You should not PURCHASE the notes if you do not understand or are not comfortable with the
significant risks INVOLVED in INVESTING IN the notes.</FONT></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED UNDER &lsquo;&lsquo;SUMMARY
RISK FACTORS&rsquo;&rsquo; BEGINNING ON PAGE PS-7 OF THIS PRICING SUPPLEMENT AND UNDER &lsquo;&lsquo;RISK FACTORS RELATING TO THE SECURITIES&rsquo;&rsquo;
BEGINNING ON PAGE EA-7 OF THE ACCOMPANYING PRODUCT SUPPLEMENT BEFORE PURCHASING ANY NOTES. EVENTS RELATING TO ANY OF THOSE RISKS, OR
OTHER RISKS AND UNCERTAINTIES, COULD ADVERSELY AFFECT THE MARKET VALUE OF, AND THE RETURN ON, YOUR NOTES. YOU MAY LOSE SOME OR ALL OF
YOUR INITIAL INVESTMENT IN THE NOTES.&nbsp;&nbsp;THE NOTES WILL NOT BE LISTED ON ANY SECURITIES EXCHANGE AND MAY HAVE LIMITED OR NO LIQUIDITY.</B></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Notes Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We are offering Trigger Callable Yield Notes Linked to the Least Performing
of the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index. The coupon rate, initial underlying levels and downside
thresholds will be determined on the trade date.&nbsp;&nbsp;The notes are our unsecured, unsubordinated debt obligations, guaranteed
by Citigroup Inc., and are offered for a minimum investment of 100 notes at the issue price described below.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlyings</B></FONT></TD>
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Rate</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Initial Underlying Levels</B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Downside Thresholds</B></FONT></TD>
    <TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-size: 10pt"><B>CUSIP/ISIN</B></FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Nasdaq-100 Index<SUP>&reg;</SUP></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: NDX)</P></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">8.50% to 9.30% per annum</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 70% of the applicable initial underlying level</FONT></TD>
    <TD ROWSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">17333P171 / US17333P1710</FONT></TD></TR>
  <TR>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Russell 2000<SUP>&reg;</SUP> Index</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(Ticker: RTY)</P></TD>
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">, which is 70% of the applicable initial underlying level</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>See &ldquo;Additional Terms Specific to the Notes&rdquo; in this
pricing supplement.&nbsp;&nbsp;The notes will have the terms specified in the accompanying product supplement, prospectus supplement
and prospectus, as supplemented by this pricing supplement. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to
the contrary is a criminal offense. The notes are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance
Corporation or any other governmental agency.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 24%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 28%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Issue Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underwriting Discount<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proceeds<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>to<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT>Issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Per note</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$10.00</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$0.10</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">$9.90</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(1) Citigroup Global Markets Holdings Inc. currently
expects that the estimated value of the notes on the trade date will be at least $9.675 per note, which will be less than the issue price.&nbsp;&nbsp;The
estimated value of the notes is based on proprietary pricing models of Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;) and
our internal funding rate.&nbsp;&nbsp;It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication
of the price, if any, at which CGMI or any other person may be willing to buy the notes from you at any time after issuance. See &ldquo;Valuation
of the Notes&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">(2) The underwriting discount is $0.10 per note.
<FONT STYLE="background-color: white">CGMI, acting as principal, expects to purchase from Citigroup Global Markets Holdings Inc., and
Citigroup Global Markets Holdings Inc. expects to sell to CGMI, the aggregate stated principal amount of the notes set forth above for
$9.90 per note. UBS Financial Services Inc. (&ldquo;UBS&rdquo;), acting as agent for sales of the notes, expects to purchase from CGMI,
and CGMI expects to sell to UBS, all of the notes for $9.90 per note. UBS will receive an underwriting discount of $0.10 for each note
it sells in this offering.&nbsp;&nbsp;UBS proposes to offer the notes to the public at a price of $10.00 per note.&nbsp;&nbsp;For additional
information on the distribution of the notes, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition
to the underwriting discount, CGMI and its affiliates may profit from expected hedging activity related to this offering, even if the
value of the notes declines.&nbsp;&nbsp;See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="background-color: white">Concurrent
with this offering of the notes, the issuer is offering other notes that are similar to the notes but that have economic terms that differ
from those provided by the notes. The differences in the economic terms reflect differences in costs to the issuer in connection with
the distribution of the notes and such other notes.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>Citigroup Global Markets Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 10pt; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>UBS Financial Services Inc.</B></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Additional Terms Specific to the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set forth in the accompanying product supplement,
prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product supplement, prospectus
supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.&nbsp;&nbsp;For example, certain
events may occur that could affect whether you receive a coupon payment on a coupon payment date and whether you are repaid the stated
principal amount of your notes at maturity.&nbsp;&nbsp;These events and their consequences are described in the accompanying product supplement
in the sections &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo;
and &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Index&mdash;Discontinuance
or Material Modification of an Underlying Index,&rdquo; and not in this pricing supplement.&nbsp;&nbsp;The accompanying underlying supplement
contains important disclosures regarding the underlyings that are not repeated in this pricing supplement.&nbsp;&nbsp;It is important
that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with this pricing
supplement before you decide whether to invest in the notes.&nbsp;&nbsp;Certain terms used but not defined in this pricing supplement
are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access the accompanying product supplement, underlying supplement,
prospectus supplement and prospectus on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings
for the relevant dates on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Product Supplement No. EA-02-10 dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 14.4pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Underlying Supplement No. 11 dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm">https://www.sec.gov/Archives/edgar/data/200245/000095010323003815/dp189981_424b2-us11.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>Prospectus Supplement and Prospectus each dated March 7, 2023:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm">https://www.sec.gov/Archives/edgar/data/200245/000119312523063080/d470905d424b2.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may revoke your offer to purchase the notes at any time prior to
the time at which we accept such offer by notifying the applicable agent.&nbsp;&nbsp;We reserve the right to change the terms of, or reject
any offer to purchase, the notes on or prior to the trade date.&nbsp;&nbsp;The applicable agent will notify you in the event of any material
changes to the terms of the notes, and you will be asked to accept such changes in connection with your purchase of the notes. You may
also choose to reject such changes, in which case the applicable agent may reject your offer to purchase the notes.&nbsp;&nbsp;References
to &ldquo;Citigroup Global Markets Holdings Inc.,&rdquo; &ldquo;Citigroup,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo;
refer to Citigroup Global Markets Holdings Inc. and not to any of its subsidiaries.&nbsp;&nbsp;References to &ldquo;Citigroup Inc.&rdquo;
refer to Citigroup Inc. and not to any of its subsidiaries.&nbsp;&nbsp;In this pricing supplement, &ldquo;notes&rdquo; refers to the Trigger
Callable Yield Notes Linked to the Least Performing of the Nasdaq-100 Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index
that are offered hereby, unless the context otherwise requires.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>This pricing supplement, together with the documents listed above,
contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials
including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures
or other educational materials of ours.&nbsp;&nbsp;The description in this pricing supplement of the particular terms of the notes supplements,
and, to the extent inconsistent with, replaces, the descriptions of the general terms and provisions of the debt securities set forth
in the accompanying product supplement, prospectus supplement and prospectus.&nbsp;&nbsp;You should carefully consider, among other things,
the matters set forth in &ldquo;Summary Risk Factors&rdquo; in this pricing supplement and &ldquo;Risk Factors Relating to the Securities&rdquo;
in the accompanying product supplement, as the notes involve risks not associated with conventional debt securities.&nbsp;&nbsp;We urge
you to consult your investment, legal, tax, accounting and other advisers before deciding to invest in the notes.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investor Suitability</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The suitability considerations identified below are not exhaustive.&nbsp;&nbsp;Whether
or not the notes are a suitable investment for you will depend on your individual circumstances, and you should reach an investment decision
only after you and your investment, legal, tax, accounting and other advisors have carefully considered the suitability of an investment
in the notes in light of your particular circumstances. You should also review &ldquo;Summary Risk Factors&rdquo; beginning on page PS-7
of this pricing supplement, &ldquo;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; beginning on page PS-14 of this pricing supplement, &ldquo;The
Russell 2000<SUP>&reg;</SUP> Index&rdquo; beginning on page PS-15 of this pricing supplement, &ldquo;Risk Factors Relating to the Securities&rdquo;
beginning on page EA-7 of the accompanying product supplement, &ldquo;Equity Index Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo;
beginning on page US-26 of the accompanying underlying supplement and &ldquo;Equity Index Descriptions&mdash; The Russell Indices&rdquo;
beginning on page US-37 of the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The notes may be suitable for you if, among other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate a loss of all or a substantial portion of your initial investment and are willing to make an investment that may
have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of each underlying will be greater than or equal to its downside threshold, and, if the final
underlying level of either underlying is below its downside threshold, you can tolerate a loss of all or a substantial portion of your
investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to accept the individual market risk of each underlying on the final valuation date, and you understand that any decline
in the level of one underlying will not be offset or mitigated by a lesser decline or any potential increase in the levels of the other
underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to hold notes that may be called early by the issuer (beginning approximately three months after issuance) in its
sole discretion regardless of the closing level of either underlying, and you are otherwise willing to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to make an investment whose positive return is limited to the coupon payments, regardless of the potential appreciation
of the underlyings, which could be significant.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You would be willing to invest in the notes if the coupon rate were set equal to the lowest value indicated on the cover page of this
pricing supplement (the actual coupon rate will be set on the trade date).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to invest in the notes based on the downside thresholds indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to hold the notes to maturity, and accept that there may be little or no secondary market for the notes and
that any secondary market will depend in large part on the price, if any, at which CGMI is willing to purchase the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not seek guaranteed current income from your investment and are willing to forgo dividends or any other distributions paid
on the stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under the
notes, and understand that if Citigroup Global Markets Holdings Inc. and Citigroup Inc. default on their obligations, you might not receive
any amounts due to you, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"><B></B></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt"><B>The notes may <I>not</I> be suitable for you if, among
other considerations:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 2.8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate the loss of all or a substantial portion of your initial investment, or you are not willing to make an investment
that may have the full downside market risk of an investment in the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not understand or are not willing to accept the risks associated with each of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the final underlying level of at least one underlying will be less than its downside threshold, exposing you to the full
downside performance of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require an investment designed to guarantee a full return of the stated principal amount at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate fluctuations in the value of the notes prior to maturity that may be similar to or exceed the downside fluctuations
in the level of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to accept the individual market risk of each underlying on the final valuation date, or you seek an investment based
on the performance of a basket composed of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to hold notes that may be called early by the issuer (beginning approximately three months after issuance) in its
sole discretion regardless of the closing level of either underlying, or you are otherwise unable or unwilling to hold such notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment that participates in the full appreciation of the underlyings and whose positive return is not limited to the
coupon payments.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You would be unwilling to invest in the notes if the coupon rate were set equal to the lowest value indicated on the cover page of
this pricing supplement (the actual coupon rate will be set on the trade date).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling to invest in the notes based on the downside thresholds indicated on the cover page of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment for which there will be an active secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek guaranteed current income from this investment or prefer to receive the dividends and any other distributions paid on the
stocks included in the underlyings for the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You prefer the lower risk of conventional fixed income investments with comparable maturities and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.25pt"></TD><TD STYLE="width: 21.15pt"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are not willing to assume the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. for all payments under
the notes, including any repayment of the stated principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Indicative Terms</B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 35%; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issuer</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 65%; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Guarantee</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">All payments due on the notes are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issue price</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">100% of the stated principal amount per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Stated principal amount per note</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.00 per note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Term</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Approximately 1.25 years, unless called earlier</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Trade date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">November 25, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Settlement date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">November 28, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final valuation date<SUP>1, 2</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">February 25, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Maturity date<SUP>1</SUP></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">March 2, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Underlyings<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white"><SUP>[1]</SUP></FONT></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Nasdaq-100 Index<SUP>&reg;</SUP> (Ticker: NDX)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Russell 2000<SUP>&reg;</SUP> Index (Ticker: RTY)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issuer call feature</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">Beginning approximately three months after issuance,
the issuer may, in its sole discretion, call the notes in whole, but not in part, on any coupon payment date prior to the maturity date
by providing notice on the call notice date prior to such coupon payment date. See &ldquo;Call Notice Dates and Coupon Payment Dates
for the Offering of the Notes&rdquo; on page PS-6.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">If the notes are called, we will pay you on the applicable
coupon payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus
any coupon otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.05pt 0pt 0">After the notes are called, no further payments will
be made on the notes.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon payment dates</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">See &ldquo;Call Notice Dates and Coupon Payment Dates for the Offering of the Notes&rdquo; on page PS-6.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon/ coupon rate</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Each coupon payment will be in the amount of $0.0708 to $0.0775 for each $10.00 stated principal amount note (based on the per annum coupon rate of 8.50% to 9.30%) (to be determined on the trade date).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Payment at maturity (per $10.00 stated principal amount of notes)</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00
stated principal amount plus any coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the notes are not called prior to maturity and the final
underlying level of the least performing underlying is less than its downside threshold, </B>we will pay you, in addition to the final
coupon, a cash payment on the maturity date that is less than your stated principal amount and may be zero, resulting in a loss that
is proportionate to the negative underlying return of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-decoration-style: double">$10.00</FONT>
&times; (1 + underlying return of the least performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion of
your stated principal amount at maturity, depending on how significantly the least performing underlying declines.</I></B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Least performing underlying</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The underlying with the lowest underlying return.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Underlying return</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For each underlying, calculated as follows:</P></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>1</SUP> Expected. In the event that we make any
changes to the expected trade date and settlement date, the final valuation date and maturity date may be changed to ensure that the stated
term of the notes remains the same.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>2</SUP> Subject to postponement as described
under &ldquo;Description of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Valuation Date&rdquo; in
the accompanying product supplement.</P>

</DIV>


<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 35%; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; width: 65%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><U>final underlying level &ndash; initial underlying level<BR>
</U>initial underlying level</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Downside threshold</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For either underlying, 70.00% of its respective initial underlying level, as specified on the cover of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Initial underlying level</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For either underlying, its closing level on the trade date, as specified on the cover page of this pricing supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final underlying level</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">For either underlying, its closing level on the final valuation date.</FONT></TD></TR>
  </TABLE>
<P STYLE="padding-top: 2pt; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt"><B>INVESTING IN THE NOTES INVOLVES SIGNIFICANT RISKS. YOU MAY LOSE&nbsp;A
SUBSTANTIAL PORTION OR ALL OF YOUR INITIAL INVESTMENT.&nbsp;THE CONTINGENT REPAYMENT OF THE STATED PRINCIPAL AMOUNT APPLIES ONLY IF YOU
HOLD THE NOTES TO MATURITY. ANY PAYMENT ON THE NOTES IS SUBJECT TO THE CREDITWORTHINESS OF THE ISSUER AND THE GUARANTOR. IF CITIGROUP
GLOBAL MARKETS HOLDINGS INC. AND CITIGROUP INC. WERE TO DEFAULT ON THEIR OBLIGATIONS, YOU MIGHT NOT RECEIVE ANY AMOUNTS OWED TO YOU UNDER
THE NOTES AND YOU COULD LOSE YOUR ENTIRE INVESTMENT.</B></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Investment Timeline</B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 3%; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 26%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Trade date</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 68%"><FONT STYLE="font-size: 10pt">The closing level of each underlying (its respective initial underlying level) is observed, the coupon rate is set and the downside threshold for each underlying is determined. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="width: 9px; height: 18px"></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Monthly </B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>(callable by the issuer in its sole discretion
    after three months)</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">We pay the applicable coupon.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">Beginning approximately three months after issuance, the issuer
    may, in its sole discretion, call the notes in whole, but not in part, on any coupon payment date prior to the maturity date by providing
    notice on the call notice date prior to such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are called, we will pay you on the applicable coupon
    payment date a cash payment per $10.00 stated principal amount of each note equal to the stated principal amount per note plus any coupon
    otherwise due on such coupon payment date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">After the notes are called, no further payments will be made
    on the notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT="" STYLE="width: 9px; height: 18px"></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #DEDFB3; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maturity date (if not previously called)</B></FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">If the notes are not called prior to maturity, the final underlying
    level of each underlying is observed on the final valuation date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B>If the notes are not called prior to maturity and the final
    underlying level of the least performing underlying is greater than or equal to its downside threshold</B>, we will pay you the $10.00
    stated principal amount plus any coupon otherwise due on the maturity date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B>If the notes are not called prior to maturity and the final
    underlying level of the least performing underlying is less than its downside threshold, </B>we will pay you, in addition to the final
    coupon, a cash payment on the maturity date that is less than your stated principal amount and may be zero, resulting in a loss that is
    proportionate to the negative underlying return of the least performing underlying, equal to:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0; text-align: center"><FONT STYLE="text-decoration-style: double">$10.00</FONT>
    &times; (1 + underlying return of the least performing underlying)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 9pt 0pt 0"><B><I>Accordingly, you may lose all or a substantial portion
of your stated principal amount at maturity, depending on how significantly the least performing underlying declines.</I></B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white"><B>Call
Notice Dates and Coupon Payment Dates for the Offering of the Notes</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Call Notice Dates</B></FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Coupon Payment Dates</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">December 30, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">N/A</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">January 28, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">February 25, 2026*</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">February 27, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">March 25, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">March 27, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">April 27, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">April 29, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">May 26, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">May 28, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">June 25, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">June 29, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">July 27, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">July 29, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">August 25, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">August 27, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">September 25, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">September 29, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">October 26, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">October 28, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">November 25, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">November 30, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">December 28, 2026</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">December 30, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">January 25, 2027</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">January 27, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">N/A</FONT></TD>
    <TD STYLE="border-bottom: #BFBFBF 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; background-color: white">March 2, 2027 (the maturity date)</FONT></TD></TR>
  </TABLE>
<P STYLE="padding-top: 2pt; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">* The notes are callable beginning on the third coupon payment date,
which is February 27, 2026.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Summary Risk Factors</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the notes is significantly riskier than an investment
in conventional debt securities.&nbsp;&nbsp;The notes are subject to all of the risks associated with an investment in our conventional
debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the
notes, and are also subject to risks associated with each underlying.&nbsp;&nbsp;Accordingly, the notes are suitable only for investors
who are capable of understanding the complexities and risks of the notes.&nbsp;&nbsp;You should consult your own financial, tax and legal
advisers as to the risks of an investment in the notes and the suitability of the notes in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the notes.&nbsp;&nbsp;You should read this summary together with the more detailed description of risks relating to an investment in
the notes contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement.&nbsp;&nbsp;You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents
incorporated by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and
any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may lose some or all of your investment </B>&mdash; The notes differ from ordinary debt securities in that we will not necessarily
repay the full stated principal amount of your notes at maturity.&nbsp;&nbsp;If the notes are not called prior to maturity (beginning
approximately three months after issuance) and the final underlying level of the least performing underlying is less than its downside
threshold, you will lose 1% of the stated principal amount of the notes for every 1% by which the final underlying level of the least
performing underlying is less than its initial underlying level.&nbsp;&nbsp;There is no minimum payment at maturity on the notes, and
you may lose up to all of your investment in the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the risks of each of the underlyings and will be negatively affected if any underlying performs poorly,
even if any other underlying performs well </B>&mdash; You are subject to risks associated with each of the underlyings. If any underlying
performs poorly, you will be negatively affected, even if any other underlying performs well. The notes are not linked to a basket composed
of the underlyings, where the better performance of one could ameliorate the poor performance of another. Instead, you are subject to
the full risks of each individual underlying. Furthermore, the risk that you will lose some or all of your initial investment in the notes
is greater if you invest in the notes as opposed to notes that are linked to the performance of a single underlying if their terms are
otherwise substantially similar.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying </B>&mdash; The payment at maturity depends
solely on the performance of the least performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.&nbsp;&nbsp;The notes may underperform a similar investment in all of the underlyings or a similar alternative investment linked
to a basket composed of the underlyings, since in either such case the performance of any better performing underlying would be blended
with the performance of the least performing underlying, resulting in a better return than the return of the least performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings &mdash;</B> It is preferable from your perspective
for the underlyings to be correlated with each other, in the sense that they tend to increase or decrease at similar times and by similar
magnitudes.&nbsp;&nbsp;By investing in the notes, you assume the risk that the underlyings will not exhibit this relationship.&nbsp;&nbsp;The
less correlated the underlyings, the more likely it is that either one of the underlyings will perform poorly over the term of the notes.
All that is necessary for the notes to perform poorly is for one of the underlyings to perform poorly; the performance of any better performing
underlying is not relevant to your return on the notes.&nbsp;&nbsp;It is impossible to predict what the relationship between the underlyings
will be over the term of the notes. The Nasdaq-100 Index<SUP>&reg;</SUP> represents 100 of the largest non-financial companies listed
on the Nasdaq Stock Market and the Russell 2000<SUP>&reg;</SUP> Index represents small capitalization stocks in the United States.&nbsp;&nbsp;Accordingly,
the underlyings represent markets that differ in significant ways and, therefore, may not be correlated with each other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Higher coupon rates are associated with greater risk</B> &mdash; The notes offer coupon payments at an annualized rate that, if
all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity.
This higher potential yield is associated with greater levels of expected risk as of the trade date for the notes, including the risk
that the amount you receive at maturity may be significantly less than the stated principal amount of your notes and may be zero. The
volatility of and the correlation between the underlyings are important factors affecting this risk. Greater expected volatility of, and
lower expected correlation between, the underlyings as of the trade date may result in a higher coupon rate, but would also represent
a greater expected likelihood as of the trade date that the closing level of the least performing underlying will be less than the applicable
downside threshold on the final valuation date, such that you will not be repaid the stated principal amount of your notes at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the least performing underlying</B> &mdash; The coupon
payments on the notes are the compensation you receive for assuming not only the downside risk of the least performing underlying, but
also all of the other risks of the notes, including the risk that the notes may be called prior to maturity, interest rate risk and our
and Citigroup Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the coupon
payments may turn out to be inadequate to compensate you for all the risks of the notes, including the downside risk of the least performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>We may call the notes in our sole discretion, which will limit your ability to receive the coupon payments</B> &mdash; Beginning
approximately three months after issuance, we may call the notes on any coupon payment date prior to the maturity date by providing notice
on the call notice date prior to such coupon payment date. In the event that we call the notes, you will receive the stated principal
amount of your notes and any coupon otherwise due on such coupon payment date.&nbsp;&nbsp;Thus, the term of the notes may be limited to
as short as approximately three months.&nbsp;&nbsp;If we call the notes prior to maturity, you will not receive any additional coupon
payments.&nbsp;&nbsp;It is</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">more likely that we will call the notes
in our sole discretion prior to maturity to the extent that the expected coupon payable on the notes is greater than the coupon that would
be payable on other instruments issued by us of comparable maturity, terms and credit rating trading in the market. The greater likelihood
of us calling the notes in that environment increases the risk that you will not be able to reinvest the proceeds from the called notes
in another investment that provides a similar yield with a similar level of risk.&nbsp;&nbsp;We are less likely to call the notes prior
to maturity when the expected coupon payable on the notes is less than the coupon that would be payable on other comparable instruments
issued by us. Therefore, the notes are more likely to remain outstanding when the expected coupon payable on the notes is less than what
would be payable on other comparable instruments.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes offer downside exposure to the least performing underlying, but no upside exposure to either underlying</B> &mdash; You
will not participate in any appreciation in the level of the underlyings over the term of the notes. Consequently, your return on the
notes will be limited to the coupon payments you receive and may be significantly less than the return on the underlyings over the term
of the notes. In addition, you will not receive any dividends or other distributions or have any other rights with respect to the underlyings
or the stocks included in the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The payment at maturity depends on the closing level of the least performing underlying on a single day</B> &mdash; If the closing
level of the least performing underlying on the final valuation date is less than its downside threshold, you will not receive the full
stated principal amount of your notes at maturity, even if the closing level of the least performing underlying is greater than its downside
threshold on other dates during the term of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Investing in the notes is not equivalent to investing in any underlying or the stocks that constitute any underlying</B> &mdash;
You will not have voting rights, rights to receive any dividends or other distributions or any other rights with respect to any of the
stocks that constitute the underlyings.&nbsp;&nbsp;It is important to understand that, for purposes of measuring the performance of the
underlyings, the levels used will not reflect the receipt or reinvestment of dividends or distributions on the stocks that constitute
any underlying.&nbsp;&nbsp;Dividend or distribution yield on the stocks that constitute the underlyings would be expected to represent
a significant portion of the overall return on a direct investment in the stocks that constitute the underlyings, but will not be reflected
in the performance of any underlying as measured for purposes of the notes (except to the extent that dividends and distributions reduce
the levels of the underlyings).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>&mdash; Any payment on
the notes will be made by Citigroup Global Markets Holdings Inc. and is guaranteed by Citigroup Inc., and therefore is subject to the
credit risk of both Citigroup Global Markets Holdings Inc. and Citigroup Inc. If we default on our obligations under the notes and Citigroup
Inc. defaults on its guarantee obligations, you may not receive any payments that become due under the notes.&nbsp;&nbsp;As a result,
the value of the notes prior to maturity will be affected by changes in the market&rsquo;s view of our and Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;Any
decline, or anticipated decline, in either of our or Citigroup Inc.&rsquo;s credit ratings or increase, or anticipated increase, in the
credit spreads charged by the market for taking either of our or Citigroup Inc.&rsquo;s credit risk is likely to adversely affect the
value of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity</B> &mdash; The
notes will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the notes.&nbsp;&nbsp;CGMI
currently intends to make a secondary market in relation to the notes and to provide an indicative bid price for the notes on a daily
basis. Any indicative bid price for the notes provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the notes can be sold at that price,
or at all.&nbsp;&nbsp;CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and
for any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the notes because it is likely
that CGMI will be the only broker-dealer that is willing to buy your notes prior to maturity.&nbsp;&nbsp;Accordingly, an investor must
be prepared to hold the notes until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The probability that the least performing underlying will fall below its downside threshold on the final valuation date will depend
in part on the volatility of, and correlation between, the underlyings </B>&mdash; &ldquo;Volatility&rdquo; refers to the frequency and
magnitude of changes in the level of the underlyings.&nbsp;&nbsp;&ldquo;Correlation&rdquo; refers to the extent to which the underlyings
tend to increase or decrease at similar times and by similar magnitudes.&nbsp;&nbsp;In general, the greater the volatility of the underlyings,
and the lower the correlation between the underlyings, the greater the probability that at least one of the underlyings will experience
a large decline over the term of the notes and fall below its downside threshold on the final valuation date.&nbsp;&nbsp;The underlyings
have historically experienced significant volatility, and as discussed above, the underlyings represent markets that differ in significant
ways and therefore may not be correlated.&nbsp;&nbsp;As a result, there is a significant risk that at least one of the underlyings will
fall below its downside threshold on the final valuation date, such that you will incur a significant loss on your investment in the notes.&nbsp;&nbsp;The
terms of the notes are set, in part, based on expectations about the volatility of, and correlation between, the underlyings as of the
trade date.&nbsp;&nbsp;If expectations about the volatility of, and correlation between, the underlyings change over the term of the notes,
the value of the notes may be adversely affected, and if the actual volatility of the underlyings prove to be greater than initially expected,
or if the actual correlation between the underlyings proves to be lower than initially expected, the notes may prove to be riskier than
expected on the trade date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes on the trade date, based on CGMI&rsquo;s proprietary pricing models and our internal funding rate,
will be less than the issue price</B> &mdash; The difference is attributable to certain costs associated with selling, structuring and
hedging the notes that are included in the issue price.&nbsp;&nbsp;These costs include (i) the underwriting discount paid in connection
with the offering of the notes, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of the
notes and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection with
hedging our obligations under the notes.&nbsp;&nbsp;These costs adversely affect the economic terms of the notes because, if they were
lower, the economic terms of the notes would be more favorable to you.&nbsp;&nbsp;The economic terms of the notes are also likely to be
adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the notes.&nbsp;&nbsp;See
&ldquo;The estimated value of the notes would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes was determined for us by our affiliate using proprietary pricing models </B>&mdash; CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models.&nbsp;&nbsp;In doing so,
it may have made discretionary judgments about the inputs to its models, such as the volatility of and correlation between the underlyings,
dividend yields on the stocks that constitute the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your
or others&rsquo; views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours.&nbsp;&nbsp;Both the models
and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the notes.&nbsp;&nbsp;Moreover,
the estimated value of the notes set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates
may determine for the notes for other purposes, including for accounting purposes.&nbsp;&nbsp;You should not invest in the notes because
of the estimated value of the notes.&nbsp;&nbsp;Instead, you should be willing to hold the notes to maturity irrespective of the initial
estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes would be lower if it were calculated based on our secondary market rate </B>&mdash; The estimated
value of the notes included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we
are willing to borrow funds through the issuance of the notes.&nbsp;&nbsp;Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the notes for purposes of any purchases of the notes from
you in the secondary market.&nbsp;&nbsp;If the estimated value included in this pricing supplement were based on our secondary market
rate, rather than our internal funding rate, it would likely be lower.&nbsp;&nbsp;We determine our internal funding rate based on factors
such as the costs associated with the notes, which are generally higher than the costs associated with conventional debt securities, and
our liquidity needs and preferences.&nbsp;&nbsp;Our internal funding rate is not the same as the coupon rate that is payable on the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
notes, but subject to adjustments that CGMI makes in its sole discretion.&nbsp;&nbsp;As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted
for discretionary factors such as CGMI&rsquo;s preferences with respect to purchasing the notes prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The estimated value of the notes is not an indication of the price, if any, at which CGMI or any other person may be willing to
buy the notes from you in the secondary market</B> &mdash; Any such secondary market price will fluctuate over the term of the notes based
on the market and other factors described in the next risk factor.&nbsp;&nbsp;Moreover, unlike the estimated value included in this pricing
supplement, any value of the notes determined for purposes of a secondary market transaction will be based on our secondary market rate,
which will likely result in a lower value for the notes than if our internal funding rate were used.&nbsp;&nbsp;In addition, any secondary
market price for the notes will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the
notes to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.&nbsp;&nbsp;As
a result, it is likely that any secondary market price for the notes will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The value of the notes prior to maturity will fluctuate based on many unpredictable factors </B>&mdash; As described under &ldquo;Valuation
of the Notes&rdquo; below, the payout on the notes could be replicated by a hypothetical package of financial instruments consisting of
a fixed-income bond and one or more derivative instruments.&nbsp;&nbsp;As a result, the factors that influence the values of fixed-income
bonds and derivative instruments will also influence the terms of the notes at issuance and the value of the notes prior to maturity.&nbsp;&nbsp;Accordingly,
the value of your notes prior to maturity will fluctuate based on the level and volatility of the underlyings and a number of other factors,
including the price and volatility of the stocks that constitute the underlyings, the correlation between the underlyings, dividend yields
on the stocks that constitute the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s
creditworthiness, as reflected in our secondary market rate.&nbsp;&nbsp;Changes in the levels of the underlyings may not result in a comparable
change in the value of your notes.&nbsp;&nbsp;You should understand that the value of your notes at any time prior to maturity may be
significantly less than the issue price.&nbsp;&nbsp;The stated payout from the issuer only applies if you hold the notes to maturity or
earlier issuer call, as applicable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment</B> &mdash; The amount of this temporary
upward adjustment will decline to zero over the temporary adjustment period.&nbsp;&nbsp;See &ldquo;Valuation of the Notes&rdquo; in this
pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Nasdaq-100 Index<SUP>&reg;</SUP> is subject to risks associated with the stocks of foreign companies</B> &mdash; Some of the
stocks that constitute the Nasdaq-100 Index<SUP>&reg;</SUP> are issued by foreign companies.&nbsp;&nbsp;Investments in securities of foreign
companies involve risks associated with those countries, including risks of governmental intervention and cross-shareholdings in companies
in certain countries.&nbsp;&nbsp;The prices of securities issued by foreign companies may be affected by political, economic, financial
and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange
laws.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The Russell 2000<SUP>&reg;</SUP> Index is subject to risks associated with small capitalization stocks</B> &mdash; The stocks that
constitute the Russell 2000<SUP>&reg;</SUP> Index are issued by companies with relatively small market capitalization.&nbsp;&nbsp;The
stock prices of smaller companies may be more volatile than the stock prices of large capitalization companies.&nbsp;&nbsp;These companies
tend to be less well-established than large market capitalization companies.&nbsp;&nbsp;Small capitalization companies may be less able
to withstand adverse economic, market, trade and competitive conditions relative to larger companies.&nbsp;&nbsp;Small capitalization
companies are less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that limits downward
stock price pressure under adverse market conditions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our offering of the notes is not a recommendation of either underlying </B>&mdash; The fact that we are offering the notes does
not mean that we believe that investing in an instrument linked to the least performing of the underlyings is likely to achieve favorable
returns. In</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">fact, as we are part of a global financial
institution, our affiliates may have positions (including short positions) in the stocks that constitute the underlyings or in instruments
related to the underlyings or such stocks, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the levels of the underlyings in a way that has a negative
impact on your interests as a holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may publish research, express opinions or provide recommendations that are inconsistent
with investing in or holding the notes</B> &mdash; Any such research, opinions or recommendations could affect the closing levels of the
underlyings and the value of the notes.&nbsp;&nbsp;Our affiliates, and UBS and its affiliates, publish research from time to time on financial
markets and other matters that may influence the value of the notes, or express opinions or provide recommendations that may be inconsistent
with purchasing or holding the notes.&nbsp;&nbsp;Any research, opinions or recommendations expressed by our affiliates or by UBS or its
affiliates may not be consistent with each other and may be modified from time to time without notice.&nbsp;&nbsp;These and other activities
of our affiliates or UBS or its affiliates may adversely affect the levels of the underlyings and may have a negative impact on your interests
as a holder of the notes.&nbsp;&nbsp;Investors should make their own independent investigation of the merits of investing in the notes
and the underlyings to which the notes are linked.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Trading and other transactions by our affiliates, or by UBS or its affiliates, in the equity and equity derivative markets may
impair the value of the notes </B>&mdash; We expect to hedge our exposure under the notes through CGMI or other of our affiliates, who
will likely enter into equity and/or equity derivative transactions, such as over-the-counter options or exchange-traded instruments,
relating to the underlyings or the stocks included in the underlyings and may adjust such positions during the term of the notes.&nbsp;&nbsp;It
is possible that our affiliates could receive substantial returns from these hedging activities while the value of the notes declines.&nbsp;&nbsp;Our
affiliates and UBS and its affiliates may also engage in trading in instruments linked to the underlyings on a regular basis as part of
their respective general broker-dealer and other businesses, for proprietary accounts, for other accounts under management or to facilitate
transactions for customers, including block transactions.&nbsp;&nbsp;Such trading and hedging activities may affect the levels of the
underlyings and reduce the return on your investment in the notes.&nbsp;&nbsp;Our affiliates or UBS or its affiliates may also issue or
underwrite other securities or financial or derivative instruments with returns linked or related to the underlyings.&nbsp;&nbsp;By introducing
competing products into the marketplace in this manner, our affiliates or UBS or its affiliates could adversely affect the value of the
notes.&nbsp;&nbsp;Any of the foregoing activities described in this paragraph may reflect trading strategies that differ from, or are
in direct opposition to, investors&rsquo; trading and investment strategies relating to the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Our affiliates, or UBS or its affiliates, may have economic interests that are adverse to yours as a result of their respective
business activities </B>&mdash; Our affiliates or UBS or its affiliates may currently or from time to time engage in business with the
issuers of the stocks that constitute the underlyings, including extending loans to, making equity investments in or providing advisory
services to such issuers. In the course of this business, our affiliates or UBS or its affiliates may acquire non-public information about
those issuers, which they will not disclose to you. Moreover, if any of our affiliates or UBS or any of its affiliates is or becomes a
creditor of any such issuer, they may exercise any remedies against that issuer that are available to them without regard to your interests.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the notes </B>&mdash;
If certain events occur, such as market disruption events or the discontinuance of an underlying, CGMI, as calculation agent, will be
required to make discretionary judgments that could significantly affect the payments on the notes. Such judgments could include, among
other things:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining whether a market disruption event has occurred with respect to an underlying;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>if a market disruption event occurs on the final valuation date with respect to an underlying, determining whether to postpone the
final valuation date;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>determining the levels of the underlyings if the levels of the underlyings are not otherwise available or a market disruption event
has occurred; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>selecting a successor underlying or performing an alternative calculation of the level of an underlying if an underlying is discontinued
or materially modified (see &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying
Index&mdash;Discontinuance or Material Modification of an Underlying Index&rdquo; in the accompanying product supplement).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">In making these judgments, the calculation agent&rsquo;s
interests as an affiliate of ours could be adverse to your interests as a holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><B>Adjustments to any underlying may affect the value of your notes</B> &mdash; Nasdaq, Inc., as publisher of the Nasdaq-100 Index<SUP>&reg;</SUP>,
or FTSE Russell, as publisher of the Russell 2000<SUP>&reg;</SUP> Index, may add, delete or substitute the stocks that constitute any
underlying or make other methodological changes that could affect the level of any underlying. <FONT STYLE="background-color: white">Nasdaq,
Inc. or FTSE Russell </FONT>may discontinue or suspend calculation or publication of any underlying at any time without regard to your
interests as holders of the notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>The U.S. federal tax consequences of an investment in the notes are unclear </B>&mdash; </FONT>There
is no direct legal authority regarding the proper U.S. federal tax treatment of the notes, and we do not plan to request a ruling from
the Internal Revenue Service (the &ldquo;IRS&rdquo;).&nbsp;&nbsp;Consequently, significant aspects of the tax treatment of the notes are
uncertain, and the IRS or a court might not agree with the treatment of the notes as described in &ldquo;United States Federal Tax Considerations&rdquo;
below.&nbsp;&nbsp;If the IRS were successful in asserting an alternative treatment of the notes, the tax consequences of the ownership
and disposition of the notes might be materially and adversely affected.&nbsp;&nbsp;Moreover, future legislation, Treasury regulations
or IRS guidance could adversely affect the U.S. federal tax treatment of the notes, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 15pt"><FONT STYLE="background-color: white">As described in &ldquo;United
States Federal Tax Considerations&rdquo; below, in connection with any information reporting requirements we may have in respect of the
notes under applicable law, we intend to treat a portion of each coupon payment as attributable to interest and the remainder to option
premium. However, in light of the uncertain treatment of the notes, it is possible that other persons having withholding or information
reporting responsibility in respect of the notes may treat a note differently, for instance, by treating the entire coupon payment as
ordinary income at the time received or accrued by a holder and/or treating some or all of each coupon payment on a note to a non-U.S.
investor as subject to withholding tax at a rate of 30%.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 15pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 15pt"><B>If withholding applies to the notes, we will not be required
to pay any additional amounts with respect to amounts withheld.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 15pt">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #00D581; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt; color: white"><B>Hypothetical Examples </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical terms only. Actual terms may vary.
See the cover page for actual offering terms.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate the hypothetical payment upon an issuer
call or at maturity for a $10.00 stated principal amount note with the following assumptions* (the actual terms of the notes will be determined
on the trade date; amounts may have been rounded for ease of reference):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Stated Principal Amount: $10</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Term: Approximately 1.25 years, unless called earlier</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Initial Underlying Levels: For each Underlying, 100.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Coupon Rate: 8.50% per annum (or 0.7083% per month)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Monthly Coupon Payment: $0.0708 per month per note</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Issuer Call: Monthly, after approximately three months, as set forth on page PS-6 of this pricing supplement</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">t</FONT></TD><TD>Hypothetical Downside Thresholds: For each Underlying, 70.00 (which, with respect to each Underlying, is 70% of its hypothetical initial
underlying level)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>*The hypothetical coupon rate may not represent the actual coupon
rate. The actual coupon rate will be determined on the trade date. In addition, the examples below are based on the above hypothetical
values and do not reflect the actual initial underlying levels or downside thresholds of the underlyings. For the actual initial underlying
level and downside threshold of each underlying, see the cover page of this pricing supplement. We have used these hypothetical values,
rather than the actual values, to simplify the calculations and aid understanding of how the securities work. However, you should understand
that any actual payments on the securities will be calculated based on the actual initial underlying level and downside threshold of each
underlying, and not on the hypothetical values indicated above.&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; The notes are called on the third coupon payment
date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 16%; text-align: center; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; width: 70%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First Coupon Payment Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0.0708</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Second Coupon Payment Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0.0708</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Third Coupon Payment Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.0708 (principal amount plus coupon); notes are called</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.2124 (2.124% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the notes are not callable by us prior to the third coupon payment
date, we will pay you a coupon of $0.0708 per note on each of the first two coupon payment dates. However, the notes are called by us
in our sole discretion on the third coupon payment date and we will pay you a total of $10.0708 per note (equal to the stated principal
amount plus the coupon) on that coupon payment date. When added to the coupon payments of $0.1416 received with respect to the first two
coupon payment dates, you would have been paid a total of $10.2124 per note, representing a total return of 2.124% on the notes over the
approximately three months the notes were outstanding before they were called by us in our sole discretion. You will not receive any further
payments on the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is above its downside threshold. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Closing Level of Each Underlying</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First through Fourteenth Coupon Payment Dates</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 33%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 30%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 23%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0.9912 in total coupons; notes are not called </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">180.00 (<B>at or above</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">90.00 (<B>at or above</B> downside threshold)*</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$10.0708 (principal amount <I>plus</I> final coupon)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$11.062 (10.62% total return)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the notes are not called by us on any of the first fourteen coupon
payment dates, we will pay you a coupon of $0.0708 per note on each coupon payment date, for a total of $0.9912.&nbsp;&nbsp;Because the
final underlying level of the least performing underlying is greater than its downside threshold, we will pay you $10 per note (equal
to the stated principal amount) on the maturity date, in addition to the final coupon.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">When added to the coupon payments of $0.9912 received with respect to
the first fourteen coupon payment dates, you would have been paid a total of $11.062 per note, representing a total return of 10.62%on
the notes over the 1.25 year term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3 &mdash; The notes are NOT called and the final underlying
level of the least performing underlying is below its downside threshold.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Date</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Closing Level of Each Underlying</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Payment (per note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Russell 2000<SUP>&reg;</SUP> Index</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 14%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">First through Fourteenth Coupon Payment Dates</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 33%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 30%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 23%; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$0.9912 in total coupons; notes are not called </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">30.00 (<B>below</B> downside threshold)*</FONT></TD>
    <TD STYLE="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">50.00 (<B>below</B> downside threshold)</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Final coupon + [$10.00 &times; (1 + underlying
return of the least performing underlying)] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$0.0708 + [$10.00 &times; (1 + -70.00%)] =</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$0.0708 + ($10.00 &times; 0.30) = $3.0708</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-top: 2pt; text-align: right; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt"><B>Total Payment:</B></FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">$0.9912 + $3.0708 = $4.062</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(-59.38% total return)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Denotes least performing underlying</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Since the notes are not called by us on any of the first fourteen coupon
payment dates, we will pay you a coupon of $0.0708 per note on each coupon payment date, for a total of $0.9912. On the final valuation
date, the least performing underlying closes below its downside threshold. Therefore, at maturity, in addition to receiving the final
coupon, investors are exposed to the downside performance of the least performing underlying and you will receive $3.0708 per note, which
reflects the final coupon <I>plus</I> a return reflecting the percentage decrease of the least performing underlying from the trade date
to the final valuation date. When added to the coupon payments of $0.9912 received with respect to the first fourteen coupon payment dates,
you would have been paid a total of $4.062 per note, representing a loss of 59.38% on the notes over the 1.25 year term of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">The Nasdaq-100 Index<SUP>&reg;</SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Nasdaq-100 Index<SUP>&reg;</SUP> is a modified market capitalization-weighted
index of stocks of the 100 largest non-financial companies listed on The Nasdaq Stock Market.&nbsp;&nbsp;All stocks included in the Nasdaq-100
Index<SUP>&reg;</SUP> are traded on a major U.S. exchange.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg; </SUP>was developed by The Nasdaq
Stock Market, Inc. and is calculated, maintained and published by The Nasdaq, Inc.&nbsp;&nbsp;The Nasdaq-100 Index<SUP>&reg;</SUP> is
reported by Bloomberg L.P. under the ticker symbol &ldquo;NDX.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The &ldquo;Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; is a trademark of
The Nasdaq, Inc. and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information, see &ldquo;Equity
Index Descriptions&mdash;The Nasdaq-100 Index<SUP>&reg;</SUP>&mdash;License Agreement&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo; in the accompanying underlying supplement for important disclosures regarding the Nasdaq-100 Index<SUP>&reg;</SUP>.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the Nasdaq-100
Index<SUP>&reg;</SUP> from January 2, 2015 to November 19, 2025.&nbsp;&nbsp;The closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>
on November 19, 2025 was 24,640.52.&nbsp;&nbsp;We obtained the closing levels of the Nasdaq-100 Index<SUP>&reg;</SUP> from Bloomberg,
and we have not participated in the preparation of or verified such information.&nbsp;&nbsp;The historical closing levels of the Nasdaq-100
Index<SUP>&reg;</SUP> should not be taken as an indication of future performance and no assurance can be given as to the final underlying
level or any future closing level of the Nasdaq-100 Index<SUP>&reg;</SUP>. We cannot give you assurance that the performance of the Nasdaq-100
Index<SUP>&reg;</SUP> will result in a positive return on your initial investment and you could lose a significant portion or all of the
stated principal amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_004.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; color: white; margin: 0pt 0; background-color: #788D41">The
Russell 2000<SUP>&reg;</SUP> Index</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Russell 2000<SUP>&reg;</SUP> Index is designed to track the performance
of the small capitalization segment of the U.S. equity market.&nbsp;&nbsp;All stocks included in the Russell 2000<SUP>&reg;</SUP> Index
are traded on a major U.S. exchange.&nbsp;&nbsp;It is calculated and maintained by FTSE Russell, a subsidiary of London Stock Exchange
Group.&nbsp;&nbsp;The Russell 2000<SUP>&reg;</SUP> Index is reported by Bloomberg L.P. under the ticker symbol &ldquo;RTY.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&ldquo;Russell 2000<SUP>&reg;</SUP> Index&rdquo; is a trademark of FTSE
Russell and has been licensed for use by Citigroup Inc. and its affiliates.&nbsp;&nbsp;For more information, see &ldquo;Equity Index Descriptions&mdash;The
Russell Indices&mdash;Disclaimers&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Please refer to the section &ldquo;Equity Index Descriptions&mdash;The
Russell Indices&rdquo; in the accompanying underlying supplement for important disclosures regarding the Russell 2000<SUP>&reg;</SUP>
Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The graph below illustrates the performance of the Russell 2000<SUP>&reg;</SUP>
Index from January 2, 2015 to November 19, 2025.&nbsp;&nbsp;The closing level of the Russell 2000<SUP>&reg;</SUP> Index on November 19,
2025 was 2,347.894.&nbsp;&nbsp;We obtained the closing levels of the Russell 2000<SUP>&reg;</SUP> Index from Bloomberg, and we have not
participated in the preparation of or verified such information.&nbsp;&nbsp;Currently, whereas the sponsor of the Russell 2000<SUP>&reg;</SUP>
Index publishes the official closing level of the Russell 2000<SUP>&reg;</SUP> Index to six decimal places, Bloomberg reports the closing
level to three decimal places. As a result, the closing level of the Russell 2000<SUP>&reg;</SUP> Index reported by Bloomberg may be lower
or higher than the official closing level of the Russell 2000<SUP>&reg;</SUP> Index published by the sponsor of the Russell 2000<SUP>&reg;</SUP>
Index.&nbsp;&nbsp;The historical closing levels of the Russell 2000<SUP>&reg;</SUP> Index should not be taken as an indication of future
performance and no assurance can be given as to the final underlying level or any future closing level of the Russell 2000<SUP>&reg;</SUP>
Index. We cannot give you assurance that the performance of the Russell 2000<SUP>&reg;</SUP> Index will result in a positive return on
your initial investment and you could lose a significant portion or all of the stated principal amount at maturity.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_005.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; font-size: 10pt; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Correlation of the Underlyings</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performances of the Nasdaq-100
Index<SUP>&reg;</SUP> and the Russell 2000<SUP>&reg;</SUP> Index from January 2, 2015 through November 19, 2025, based on the daily closing
levels of the underlyings.&nbsp;&nbsp;For comparison purposes, each underlying has been normalized to have a closing level of 100.00 on
January 2, 2015 by dividing the closing level of that underlying on each day by the closing level of that underlying on January 2, 2015
and multiplying by 100.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the closing levels used to determine the normalized closing
levels set forth below from Bloomberg, without independent verification. Historical performance of the underlyings should not be taken
as an indication of future performance. Future performance of the underlyings may differ significantly from historical performance, and
no assurance can be given as to the closing levels of the underlyings during the term of the notes.&nbsp;&nbsp;Moreover, any historical
correlation between the underlyings is not indicative of the degree of correlation between the underlyings, if any, over the term of the
notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_006.gif" ALT="" STYLE="height: 315px; width: 577px"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE AND CORRELATION BETWEEN THE
UNDERLYINGS IS NOT INDICATIVE OF FUTURE PERFORMANCE OR CORRELATION</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Correlation is a measure of the extent to which two underlyings tend
to increase or decrease at similar times and by similar magnitudes over a given time period.&nbsp;&nbsp;The closer the relationship of
the returns of a pair of underlyings over a given period, the more correlated those underlyings are.&nbsp;&nbsp;Conversely, the less closely
related the returns of a pair of underlyings, the less correlated those underlyings are.&nbsp;&nbsp;Two underlyings may also be inversely
correlated, which means that they tend to move in opposite directions from one another.&nbsp;&nbsp;The graph above illustrates the historical
performance of each underlying relative to the other over the time period shown and provides an indication of how close the performance
of each underlying has historically been to the other underlyings.&nbsp;&nbsp;However, the graph does not provide a precise measure of
correlation and there may be relevant aspects of the historical correlation between the underlyings that cannot be discerned from the
graph.&nbsp;&nbsp;Furthermore, regardless of the degree of correlation between the underlyings in the past, past correlation is not indicative
of future correlation, and it is possible that the underlyings will exhibit significantly lower correlation in the future than they did
in the past.&nbsp;&nbsp;We cannot predict the relationship between the underlyings over the term of the notes. For additional information,
see &ldquo;Summary Risk Factors&mdash;You will be subject to risks relating to the relationship between the underlyings.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The lower (or more negative) the correlation between the underlyings,
the less likely it is that the underlyings will move in the same direction at the same time and, therefore, the greater the potential
for one of the underlyings to close below its downside threshold on the final valuation date, respectively.&nbsp;&nbsp;This is because
the less correlated the underlyings are, the greater the likelihood that at least one of the underlyings will decrease in value. However,
even if the underlyings have a higher correlation, one or more of the underlyings might close below downside threshold on the final valuation
date, respectively, as all of the underlyings may decrease in value together.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the notes are set, in part, based on expectations about
the correlation between the underlyings as of the trade date.&nbsp;&nbsp;If expectations about the correlation between the underlyings
change over the term of the notes, the value of the notes may be adversely affected, and if the actual correlation between the underlyings
proves to be lower than initially expected, the notes may prove to be riskier than expected on the trade date.&nbsp;&nbsp;The correlation
referenced in setting the terms of the notes is calculated using CGMI&rsquo;s proprietary derivative-pricing model and is not derived
from the returns of the underlyings over the period set forth in the graph above.&nbsp;&nbsp;In addition, factors and inputs other than
correlation impact how the terms of the notes are set and the performance of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>United States Federal Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the notes. In connection with any information reporting requirements
we may have in respect of the notes under applicable law, we intend (in the absence of an administrative determination or judicial ruling
to the contrary) to treat a note as a put option (the &ldquo;Put Option&rdquo;) written by you with respect to the underlying shares,
secured by a cash deposit equal to the stated principal amount of the note (the &ldquo;Deposit&rdquo;).&nbsp;&nbsp;In the opinion of our
counsel, Davis Polk &amp; Wardwell LLP, this treatment of the notes is reasonable under current law; however, our counsel has advised
us that it is unable to conclude affirmatively that this treatment is more likely than not to be upheld, and that alternative treatments
are possible. Moreover, our counsel&rsquo;s opinion is based on market conditions as of the date of this preliminary pricing supplement
and is subject to confirmation on the pricing date. Under this treatment:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>a portion of each coupon payment made with respect to the notes will be attributable to interest on the Deposit; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the remainder will represent premium attributable to your grant of the Put Option (&ldquo;Put Premium&rdquo;).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will specify in the final pricing supplement the portion of each
coupon payment that we will allocate to interest on the Deposit and to Put Premium, respectively.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming the treatment of a note as a Put Option and a Deposit is respected,
amounts treated as interest on the Deposit should be taxed as ordinary interest income, while the Put Premium should not be taken into
account prior to maturity or disposition of the notes.&nbsp;&nbsp;See &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences
to U.S. Holders&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the notes. An alternative characterization of the notes could materially and adversely affect the tax consequences of ownership and
disposition of the notes, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS
requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar
financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore,
members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations
or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment
in the notes, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative tax treatments of the
notes and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders. </B>Subject to the discussions below and in the
section of the accompanying product supplement entitled &ldquo;United States Federal Tax Considerations,&rdquo;&nbsp;&nbsp;if you are
a Non-U.S. Holder (as defined in the accompanying product supplement) of the notes, under current law you generally should not be subject
to U.S. federal withholding or income tax in respect of any amount paid to you with respect to the notes, provided that (i) income in
respect of the notes is not effectively connected with your conduct of a trade or business in the United States, and (ii) you comply with
the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&mdash;Dividend Equivalents under Section 871(m) of the Code&rdquo; in the accompanying product supplement,
Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;)
generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial
instruments linked to U.S. equities (&ldquo;Underlying Securities&rdquo;) or indices that include Underlying Securities.&nbsp;&nbsp;Section
871(m) generally applies to instruments that substantially replicate the economic performance of one or more Underlying Securities, as
determined based on tests set forth in the applicable Treasury regulations.&nbsp;&nbsp;However, the regulations, as modified by an IRS
notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based on
the terms of the notes and representations provided by us as of the date of this preliminary pricing supplement, our counsel is of the
opinion that the notes should not be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations
with respect to any Underlying Security and, therefore, should not be subject to withholding tax under Section 871(m). However, the final
determination regarding the treatment of the notes under Section 871(m) will be made as of the pricing date for the notes, and it is possible
that the notes will be subject to withholding tax under Section 871(m) based on the circumstances as of that date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">A determination that the notes are not subject
to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its
application may depend on your particular circumstances, including your other transactions. You should consult your tax adviser regarding
the potential application of Section 871(m) to the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>While we currently do not intend to withhold on payments on the notes
to Non-U.S. Holders (subject to compliance with the applicable certification requirements and the discussion in the accompanying product
supplement regarding &ldquo;FATCA&rdquo;), in light of the uncertain treatment of the notes other persons having withholding or information
reporting responsibility in respect of the notes may treat some or all of each coupon payment on a note as subject to withholding tax
at a rate of 30%.&nbsp;&nbsp;Moreover, it is possible that in the future we may determine that we should withhold at a rate of 30% on
coupon payments on the notes.&nbsp;&nbsp;We will not be required to pay any additional amounts with respect to amounts withheld.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the notes and any tax consequences arising under the laws of any
state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-family: Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #788D41">
    <TD STYLE="width: 100%"><FONT STYLE="font-size: 10pt; color: white"><B>Supplemental Plan of Distribution</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
lead agent for the sale of the notes, will receive an underwriting discount of $0.10 for each note sold in this offering.&nbsp;&nbsp;UBS,
as agent for sales of the notes, expects to purchase from CGMI, and CGMI expects to sell to UBS, all of the notes sold in this offering
for $9.90 per note.&nbsp;&nbsp;UBS proposes to offer the notes to the public at a price of $9.90 per note.&nbsp;&nbsp;UBS will receive
an underwriting discount of $0.10 for each note it sells in this offering to the public. The underwriting discount will be received by
UBS and its financial advisors collectively.&nbsp;&nbsp;Investors that purchase and hold the notes in fee-based advisory accounts will
pay advisory fees to UBS based on the amount of assets held in those accounts.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">See &ldquo;Plan of Distribution;
Conflicts of Interest&rdquo; in the accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying
prospectus supplement and prospectus for additional information.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: #788D41; color: white"><B>Valuation
of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the notes set forth on the cover
page of this pricing supplement based on proprietary pricing models.&nbsp;&nbsp;CGMI&rsquo;s proprietary pricing models generated an estimated
value for the notes by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the
notes, which consists of a fixed-income bond (the &ldquo;<B>bond component</B>&rdquo;) and one or more derivative instruments underlying
the economic terms of the notes (the &ldquo;<B>derivative component</B>&rdquo;).&nbsp;&nbsp;CGMI calculated the estimated value of the
bond component using a discount rate based on our internal funding rate.&nbsp;&nbsp;CGMI calculated the estimated value of the derivative
component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that constitute the
derivative component based on various inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the
notes prior to maturity will fluctuate based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or
Citigroup Inc.&rsquo;s creditworthiness.&nbsp;&nbsp;These inputs may be market-observable or may be based on assumptions made by CGMI
in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The estimated value of the notes is a function of the terms of the notes
and the inputs to CGMI&rsquo;s proprietary pricing models. As of the date of this preliminary pricing supplement, it is uncertain what
the estimated value of the notes will be on the trade date because certain terms of the notes have not yet been fixed and because it is
uncertain what the values of the inputs to CGMI&rsquo;s proprietary pricing models will be on the trade date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">During a temporary adjustment period immediately following issuance
of the notes, the price, if any, at which CGMI would be willing to buy the notes from investors, and the value that will be indicated
for the notes on any account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial
information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>This
temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term
of the notes.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>The amount of this temporary upward adjustment
will decline to zero over the temporary adjustment period.<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</FONT>CGMI
currently expects that the temporary adjustment period will be approximately four months, but the actual length of the temporary adjustment
period may be shortened due to various factors, such as the volume of secondary market purchases of the notes and other factors that cannot
be predicted.&nbsp;&nbsp;However, CGMI is not obligated to buy the notes from investors at any time.&nbsp;&nbsp;See &ldquo;Summary Risk
Factors&mdash;The notes will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>&copy;</SUP> 2025 Citigroup Global Markets Inc.&nbsp;&nbsp;All
rights reserved.&nbsp;&nbsp;Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are
used and registered throughout the world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->




























<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><SUP></SUP></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  2  D# 2(  A$! Q$!_\0
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G)@A+V:,1OC *8;/&TD$]<].?4?)D_P"?J7\D_P#B: )J*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M X"[1M-8(\XS^?A#R\?_!#EDD4<FN>3Q3D(I)96@7)GE/_T T@@VR_7O__\
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MO>00_A#E_UT1D6P15-$(^O^PSNP@#IS0#'FZIX+EIX40J(,ZRO: J"8G$/.
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MCJ::(VHUHFZ#C:!8OLUMM]Y$ 4XXXHRS)3E:F',.="YDBE048QD'1& "%;A
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MP. %0SB$!<:&0"@$82"(=>@%6R@$C2$%69B$4$QHA8Y!<> &"H"2F2*"@4"
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MH(=^:.Q@2 5WB!Q6Z 5(GFI-Q[IX8-AAMP3/J.1\691I< H% &89B"5Q@$\
M\(!7']"<B :G6(%6X)O.&(!.'F:<V 7_/5B&?I#X9^4':7 -??@&5D@-:0BZ
M00DG=BB%:I#.8! &>;F'YBD&7Q!,?VB%L=EA=T^_=*B"W.9!>? "N:D!I&Z4
M>5@%V78*-DGBIB $E',*Q<")Q5OB/6H*#1 [ "!58\<)4:V!%6C-IZ^)<2C9
MHFAWF/>G>H@1E7XESZ #@JAE"DC%1U$!SZ!I;1#M0PC[IKA-G/!?IR !_06
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M,E;_NI'JE[!=KW&N]/%+U<Z@MFK_O FSI^I?,5P*K9U"ZO<OX,""!_\3?J9
MY+-_KR!5:KQ$Y ,4R1S2<R!AQSS"%,'!$ H@ P0!*!L=&X R1,-XC4LI++;
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M\0Q6X.H?]KC%7IIEQU&2<B*- -<%4#(*\+W"- #_8(U#E.%*H73A'^,32@$
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M- Y#-* &MIHZ>-!(/(0@'(9([, *UJ"PJ-]?J(/9'84*VN">Q8)-'$U#]$,
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M_1F"+Q!2-!@"+<#N?)Z?-[0I;(B .CS"TZ2-'7CK!@2"++A=1YC#/AB"3?P
MF@7ZC<YX.BB#,<A#E!H$/L#"/9S",)A#*,2#-] "/-1",G"#+-#/-HC"OD4#
M.<1"/O!"9*8YN0%#&W2&9_# (G#!-Q222," 0MC#&63"IF_$)]B$_\JZF0O_
MLT:$0RHTUSO,QC'_ SV@PC;472X4PS(W<[V9;C1#ZC0W8\6Q0C4,C#D8 AF0
M01)P< -<0B8\_(K]@SP\_#(+1BGP[(6J^XU.KE&$0QU @S3@0@\=],@E-#K2
MZC_8ZI(T]$-CH#\\PB-< S+,/,W7O,W?/,[GO,[O/,_WO,___,P[0S)H ]%[
M0SP\ Q(\@ *XP![8P*&T@#3D ^@5 S+(/#(X ^C90\T# ]!W?3-0H01X@-YT
M/=F7O=F?/=JGO=JO/=NWO=N_/=PW0RS$YTS(@\JY @BF-4NN=;B%8L/^ US_
M2L0R \7:PO.0 J_M@^(O/N,WON,_/N1'ON1//N57_W[ETX,$[8,53 #G=X >
MX #YG!8:^$,[6+[IG[[BDT,+B 0JG,,^E#[JQ[[LSS[MU[[MWS[NY[[N[S[O
MG_XL!+A'B ,I=$,[%/1@2BD]@,(S*'<^8$,KP,,L<$,QZ$(XZ ,X&,,LD,,L
M3 ,YN,(^$,,B<1;Q[ED\I *\A#@ I(#<ZL)O2XL+B 1H:OR!$KA1R(,HI,)D
MV$.W*T,@K$)Q%!M F*+W[UPJ0^_^H3/V#U0@5>+^10L$J]P_B\1(6=2XD6-'
MCQ]!AA0YDF3)?X(J %"YDN6  RRS>'IQ0Y5)FS<Y\J/6#)0\G#^!!A4ZE&A1
MHT>1)E7JD1>YI1O/85N*\?]I5:L;T2E;P)*K2B/='M7RY&C>OW#AKJ95NY9M
M6[=OX1YM>E4?6J54X^;]^*K,,$@J*#C@J@-4&P\KB>E5O)AQ8\>/X\Z%7!+O
MY+:?F'1=N8$6J6@6SRF*M,MR:=.G4:>&*QEI.6# D-G]9PY8/HO@NB&TR"T;
MOXWCD.VS&.Z:NXV552N]!H>#YI6*DD>7/IUZ]9"LCY::Y(L4.XOE3-$Z1(W?
M*52%O/VS9NO7+-__R*5R=:A>NE"P'EW3B-PZ4&UN)&!)@@PTF,"#"0K@9)S^
M&&S0P0??PJZH=&!)QBF-H$E,&E'<(6V=7_S1Q2);[K%HF&;^:887:5XAR!2-
MM#G_!4*3^GEGB*Z8^(8;=I311QGA9@Q2R"&)).F5"X_21Y-;=-%&'XMJ.>:?
M<7Y!1L9_!LG&%HM^D<8B4Q9"QQ5EA/D'GDDL4L>74-@AQ\TWX8Q3SCGIE*=-
M.O',\TUV9+-H'7:($664-9C()9Q38(&D PQPS"<=<,I)9YUTPKE3STLQS533
M33GMU--/00U5U%%)+=744U'==!?OD@+'HE"<L4@4*<GII9DK#=DF%RZ]_*>7
M,%?1ILPS+;KGD$.0B4;999EMUMEF7D,&&V>516:9:9;!1]MMT4F6VF^=1<:8
M5_+00HLA@N"!@0!7LH &YR[8H9=NK@'7WGOQS5????GM_]???P$.6."!"2[8
MX(,13MA99E Q)RE]NK%(%_W^@4:;?^)I)9Z:U''%GU4D]L=$8/[9AAAJ6/FG
M'5<TJH:TJWBAXY-!:*Y9%HB$<D4&YWAFR8MGD"Q2Z*&)+A*4H(L2QY=:=A$&
MG'&*@0<55P;!YY]=8)$%16]ZN044?OK!AYU?1#'$GW1TT640;O;+2*1ESK%H
M''3^ 4>_3&*( 89%<&F'HV1\Z%FJD)B)V*-E<KB@9YZCJ.&-)XN.7/+)K9/0
MJ&VN@6@94/Z9!QKC_E$'&VHTFL:9=. 3N9UC2OQG'6;L.<YMC0;5)9ML_JD$
M@@6VL*,&!'! P0$JI.#*!%$VXO]D<2\6[.B5$6K ((-&_O%&E.N'>6?G=K%8
M8J4TL#DDB*Z\X(=5RM%/7WW(+$^*':OOFL6B=-9@8;,$[OAA\:ZT",:34:X1
M@_W-+B&\  *C5E*!* 2 )8=9B0AJ\@\DP  )MOF'/Y:P R]\@Q&!.-_Z0!A"
M$:ZE?:I1AB\L%HC]K1  !5") !K0E1F$@"LLT(8VI!$)#;"0)7?82#G4T1%Z
M!'&$133B$9%20J+  T@6F0<V0*<.8/2*']N8!NHTTHYHM&X=S:";1I0! Q[R
M; ]KV)YSN  )28AL%K3( 5<8(!B6'.",SE$#$O&81STF$6E&X4<A'*$1\*SB
M$-S@!RG_0B&(BQ'C%Z8@Q7O&D0I1',(=Z8B%+AZ!#(T$HRL(7,D%.G "-.AA
M$KVXQ!PH48,?_  ALWB)9NX0NXVD0P<]VX$AGH$-KBC@!Z_T03_V&$QA#G,D
M2A1*,&B1"HT<PQK_*,8JXD&:<H!(1/^P!3#_(0Q-(H,7U.!</WH!HZ[<HA1.
MN ,;XL *PXE$'#M4R0!64@B/\&,/%G . R+XCU<THA%G<(,R_E$"E4B)F 4U
MZ#"/I!1D:*,=LM!(E*94I2ME:5?_Z-*7PC2F8:$I=*1@B0#@$ ]^D.-1\$B'
M.N3AIG&,0Z7SD$=*R6&,Y@!@ ^,#0 ;J08Z5[I2E_M #/+ER_X-FT&.E)+5(
M7<0ACT#4H0[<X.E3H1I5J4Z5JE6UZE6QFE6M;I6K7?7J5\$:5K&.E:QE->M9
MH;JJI$PC$.< !B4@!]%:W<HBALA&17NQ#(PF)%C#>H1%]J$)'2PA$;+@A3VN
M@8UK- ,9TL+&8R$;6<@"PQ4$D$ %@K&+*K!A$-UHAF0?>XUC# ,58@1  U+A
MC&0X-K*-?>PRXA&/Q(*6MK6U[6UQFUO=[I:WO?7M;X$;7.$.E[C%->YQD9M<
MY>HV&K%P&%*8\0A3$&(-S8M&,_$Q"G?XPBRKV ?(_J$+( 5#D].PAC12]K&6
M(<\H]X@&,W#RA@$,  <'M>]]\:N1H_\]Q1_*I,<RX!$+6@@B'O_P!2H,H<EJ
MV*(7*<L'.N;1"UT88A_\< 4L!D&ZB[Q,+_Z0AC2^F%\1CUB/QA0*. 92C)29
M QMQJ]LUBJ&1;"3#-^3PVSBB :1P-*/ ;2/QCX$<9+GT,2GSZ'%2^"-D)2^9
MR1TQL6F2W&0I3YG$3_Y),C2L$7(<XXOAB ;N_L$/9P #9Q;QQS-<+ ]HQ-C'
M5';SF_%K99ND8Q:B",4S-+*.7M3B$+T1!2T&D9AOF.(6HG@//5)!BD/$0QRH
M6$4@4'01 L*9TI7.HYQ-H@_]Q,.A%GG&Q=ZQ"GQP%QZ_N$<U?X%-4)#L&J7@
M1LKN$4Z+*$/_?I:V]:U'F%"%<N(SLI(2E9KA-D'H:D2]^E5"FC2L0PS'//1H
MQ[.A'6UI3YO:U;;VM;&=;6UOF]O=]O:WP1UN<8^;W.4V][G1G6YUKYO=U9[%
M!X\BCWKHHL=R-05=_R$++5DDKU]B&S[Z:J:_7O 1DP!&,Q"><(4OG.$-=_C#
M(1YQB4^<XA6W^,4QGG&-;YSC'??XQT$><I&/G.0E;S@VG-LJ@MXBTMA(C#U*
M40_NEF,5[0"O+OSV#V*@J!O:V-P_[@'>?SR#N[@V^M$GMU^DT-G1JH!'.ZBA
MCE@DTCBJN,4@]'.,5-BB3.>PASQZ 0M#M(,?JT"%(/0J::2OG>U$_\*T3:B1
M#-2IV'7 P*8^IB'+?U!C(?]@QT#8@8R!F.D:]9!=VQ&?> :]_2?RGLJD%1]Y
MR9>&\8Z)\N0QG_F\5)XDV7C&.C9"#V_HIAS'2,;\I 4YB_1#&:";1S6RK'/(
M:Y[VM5<+YT,B#FO,8A6&8)4Y?K&+26PC':L0A2R"\8]AX"(6KGC//E+ABT.@
M0QRX.$4A>BU[VV^?^U;!/4CTP;9_W*+7U0"H/5R!#NZJ(]6HMB H]..,4A@C
MO;\ 8ZV[GW_]#T772A&'*PSO'V8EHH+-(H:MHFS!V,(DV<QDV?ZA'&H!%_;!
M'RBP BWP C$P S5P SFP SWP T$P!$5P!/])L 1-\ 11, 55< 59L 5=\ 5A
M, 8U\!3*8BF@(5:@1$K8X=ZN1-^VQ%?2SA3^312T81A"9^#\X1'RH[&8L F=
M\ FA, JE< JIL JM\ JQ, NU< NYL N]\ O!, S%< S)L S-\ S1, J;(>62
M@A^Z(>TLHAF^X1_>H13.P4-6@1YN+N>L02J<01N*H47Z@;V&KNCV[Q 1L218
MH7F0XA$NP15TP1QB"AQ@X18$(6Y&X1<*(6*@P1"0[Q_JH1C,H1=PP1 &0A1,
MH1#83/L2L15=T<F(;"@48AJZ01WLH4S"H1N 1!RRX<B6H5?F84'FP1DN1!VF
MP8+4[A65T16_KR3_Y,'%D&SVEG$:MZ\9]>+RJ#$;,\\:0<(?B BPSLM/O $'
MQ2$:H.$;09$8X(<<M ',DE$;X9'VN+$CTF$;R  9Y>$75.$1KL@52"$7AH$?
MA"$4:$$7L*B_1N$0[$$?<&$7! $:VBP>)7+RYO%O1*$1CLP;T@,?TH^[P*']
M^,V"7B%6NF$4LJ%,VL'^+,(;\&\B71+Q^N\HT"(50DP4\ S8A&T;E,F:%!#9
MM"%EX,$!RT$4;L$?[N$HD3(IE7(IF;(IG?(IH3(JI7(JJ;(JK?(JL3(KM7(K
MN;(KO?(KP3(LQ7(LR9(I^X$&GV(00JP6('('D:'6?/!+TNX6AE 9C% =_P(!
ML HA$.CE&OSR+P$S, 5S, FS, WS,!$S,15S,1FS,1WS,2$S,B5S,BFS,BWS
M,C$S,S5S,P43&$+!)Y:B$/0.&9)O&7@A'TA#'D1!#WU#%P9/&SX#&)3A'7B!
M(&I!(XCN)76S[1;Q*5+!:OQA&\"!%DQ!$&RC%&RA$*8A(@9!%A(C%,V!T&1A
M04BA%T0S(G<S.V^M(CO"'""B&(P0'K)A\-)!&J 1'71#$F<C&VI0'XQ!9+!3
M.^43SKCS(Y[Q\>8S/^DS%E,#&_7S/W^L/MO"/P&T0..,/]GB'09!$-9)'':A
M$'0!'M0C$'IA\%C10#&TRA!4+<+!%?#A'&3AN?^NP1?"@12J81\B41D(D4 S
MM$6#24!QXAQNP2)N@<UH@730@2T3(QP$02.\(9]<-$@+JC?U A]Z]!]20<-L
M 7?L@1:(@7/@ 1"*Y1#FX!>L]$JOU! & 4NY]!<"@3VZ]$H#(1?"U$I3H1#*
MU$H+(172-!<"(4U_P1;>-$T'P1#@=$[+5$OO%$S+M!#(M$S/%$[7M$WQ-$P%
M01;25$[AM$[A5$_3]$O35!8$X4[_-$P#E5#A]% 3M5"[E%$?M5&W]%'Y-$S'
M-$TOM4_9M$S=-%,1E4[M]%/3U%'+%%+3U$\?M5+#=%!5M5!3P1&>*R_Z(18L
M@A;@IQ9()[NPH9G@0=;_P $9E($>[J$?I+4?]B%:M<$:H'5:I;5:^X$6\B%;
MI_4>]D%::^$=VD%;I;4=[J$;5&$<_ %=_>%<=\$8U!5=)Y ;2,%=T95:_0$=
M5F$<QE5;V^%=08$8]C5>^R$?0N$<]G5@^\$:0.%@LS44T&%?^^$>Z.%CE@%<
MI]4?Z*$;9@%@]Y4>]H$4MH%CI=5CJ4$41-9>Q^$5@*%>M15CSX%EW]5E@^$8
M4#9EZ>$8@F%G[Z$=QD$4ZN%FM=5CN4EFPU5H2>$= A9=VR$9VO5IT94::,%B
MIU45H %K^\$>0H%K^P$4K,%B_<%=0R$?Q'5FA58;(I8"CW8<Z $6T"%MCY8>
M_^C!%8R!6J,579TA9(T674EA//<678V!9:E66WT!&'9V6L7V<*=582\6:ZV!
M%1QW6D,A'@976NF6%(KA7+656W7!'O0U7 -V%Y+!<Z=U ON!&O+5:#=4+?1A
M%Q3+%=0!'LJA&#Q4%XQ!'F#A'4;!&L#!-\2A&*!Q?HZJ&)!1([!('.(!=&;)
M(MH!'4!S(\+!-^P!?CBB+-C!'OH(')X$';!WEB34'?"AS+Y#)"H")/K$(T!/
M).X!(O"AB92W1,@!'[!H(_8AB##7(VQC'O#!53BB'/ A'\ZA!CDB']RA'XI7
M(]3A0\^!R-(A'NHA'^17R_!!&HZ,(^KA'3;6(^0!'_^RY3TX(ASL ;;0D3'B
MP4+OUR(^&')$6"/<H8E6&#20<88M."3<(><\PG]?6(-;QS$.#<)R H;#UWC]
M3G2'V"+ =S+: 1=N(6[P@72\018"\A^2(15F01\Z@1SD 14D01)* 8#_ 1/*
M80<E01% 0?7^01'B 1Y681,DX132]Q^N@1+^01H8X1,8P1V=Z1*H(1;@V&PT
M@A],01:, 1$D 1$2 X8O81IJH1,^X1&<5V4LX1A881,^81%Z)<S:(!-.X1Y^
M52-*80],X1K@DR/8X!-<(1\,&#?-P!:BX6PZ0A^J(1%(P1<@P1+F4"/P(18R
MX1GRF!%J.!HH 19X 1(P813_1#@?7 $1O&$2/L$1PC<;#.$3K* -_"!E- (>
M1@$0R. (RB 2Y+<84D$2JL -^* E_\$=3($3N* )R.!%&#@7).$3%,$1'J$:
M-L(9),$3OK@13.%\T@$5/L&>,^$1=EDC9F$3%$$1.&$22N&'V.%=[R$?\B&4
MVR1R\Z$?[K=2*-JB6SFCH]6B58\</B$2,J$5TH$<+&$CM,$.(GD;K"FB_201
M_B 32,%[(V$C]"$0^, 38*$L,.&#,,D9*B&2+30A&&$4AN$2+&&1%1H0@ &:
M%P&;5F\13D$9D)FF-2(7%B$0 ,$/GH 0+!0=%&$0 *$1@& 3#/$?0J$2"@$0
M[D +_Q8A (%.$@J!GX2@#(3N'Z;!CI=A$3ZA$F1:(RKA=%2AH(.:ER4A(1I!
M$AR!8BPB$"X&%#CA$VY!AZGC#/X!%\ +$ R1LVVAZ"J!<S2"#,)!%532%H35
M(HX!.N; .\2A#@P8$KHA& +I'UR!$#2B&-C@'^H =-X &A/A&ZZAI1D".C0B
M%5!A'_C (KIA#C0"'-C &$Y!$3SA$0*!$6$!$*Y!$#"!$!JA133"#Z9!%3CA
MH0\!&4?!$YQ!%C"!$0"!P_[!&7PHL2WB#<ZG$])##?1J%J34(NS!#_ZA&O[
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M#DD_R"L22>!").O( TG (&V/G.*8(=G#LC]BC3",! _$#LDE@NZ1?)AA)(E
M!>&?,!)!'%8D3TA\1US1X) 0@^XB84/E/^*,FXKD#S@/22)R(1)PY.'H@DAM
M2.BP3<GN,R1BV/E'6"%YD;P!@2#Y ^8[<H\]C(03MRBSX44R"4",A!3_$XGC
M<Y[\D%!^))<7B>9'H@G/AZ0<H)>[E?>!#5OL@]W_8$?&W@%KC\AC'_Q/AB'V
MT?]RC#(7T. /UC!G754,_?%PTN 0Q' <$Q$._+</[O (^Y!L*(<0H& .*'86
M^T ,M+ /D?4/QW 5M9!X\R"!T- +^Z!FU& :UD ._N81\+ /J* -4,</WZ /
MZU ]>M(.$B@*H$ /KS4[H# /2:<Z^Z *N] .9W8_CN(*]/</Y""!P^ *(?@1
M=30/U< -F79E^V +P)!X\#!0^S +'I$.$K@/N. -4&=->3(-[U -IC<.Y_ (
M_8!E[@!AV("$&Z:&CX // ,4K5(/R' -QJ=2^U (U!!\]9<Q]A!PGJ&&N> ,
MIH</<\$,!7B ])" ^_!PR^ 0UL!\_Q"!_%</C^ /%TC_#FC##<; ##6'$/S@
M@;" A1U!@O]@@AZ!@ORG@BQ8'[\!@S+(%S5X@QZ1@SO8@V=!#Q)8"T)(A!G(
M#GWH?E>R#I!0!I_@"9&0=O6P!L40#OHP#Y%U"I% "8L "(+ 7V<Q"E5@!K*
M"JFP!YC%#XS !YV0")$ 81W!"Y!P#^  #X(X39'@"(NP"(/ "$_S#_,0"R+P
M";(0"Y@P1!,Q#F00"8K "9A010A!";TP#^E@#E^&"YA0"8MP"(7 "/$"#J1P
M!&_@D(#@31[1#6T0"9[P"4B5(WX #>:0#O/ ;NJ0")M D($P"88 (?[0"R[
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MQ8#,!S2[$G? "ZQ0"5G;$>&0"W[@"79@I:JC=PC1"I%\*A;)"9W "0_W"(G
M"J]P!S66(J=0!VW:!W/&!L&6#4[<&)D R'] R>MP";; "JMP!F[W+H?@!XF
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M3,D[D"'-A]CC%8"<)1?!Z8]1\,HEV2 F./^1C5NF!!J;_Y2F-ZZQ/V6<#YS
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M  ;D0A VN, R1 & 2=0! ,:  P"6L0\%A. 8GY #)'M[7>QF5[L3Y<<'I J
M#;0&& 9@0!8 D I#7& 'Z!B$!U)  $SP;KOSI6]][=L3:'SC&\2HESU T8YG
M8) 9I> *-WR!P?LF6,$+9G"#'?Q@"$=8PA.F<(4M?&$,9UC#&^9PASW\81"O
$-"  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_005.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
M    00([ 8<    5%14;&QL! 0$='1T>'AX1$1$.#@X*"@H" @(# P,2$A($
M! 04%!0-#0T9&1D6%A80$! 7%Q<<'!P%!04&!@83$Q,(" @:&AH/#P\+"PL,
M# P8&!@'!P<?'Q\)"0DF)B8D)"0M+2TJ*BHC(R,E)24N+BXT-#0L+"PP,# @
M(" B(B(V-C8Z.CHG)R<I*2DU-34X.#@Q,3$Y.3DO+R\_/S\]/3T^/CXS,S,K
M*RLA(2$R,C([.SLH*"@W-S<\/#Q24E):6EI(2$A<7%Q34U-;6UM'1T==75U/
M3T])24E*2DI"0D)#0T-04%!%145?7U] 0$!.3DY&1D965E986%A,3$Q145%4
M5%1!04%>7EY75U=5555-34U+2TM965E$1$1G9V=R<G)U=75^?GYP<'!V=G9]
M?7UQ<7%J:FIT='1[>WMX>'AB8F)H:&AK:VMM;6UO;V]N;FYI:6EF9F9C8V-\
M?'QY>7EZ>GIS<W-A86%L;&Q_?W]W=W=E965@8&!D9&28F)B-C8V:FIJ=G9V>
MGIZ;FYN2DI*1D9&.CHZ<G)R?GY^7EY>%A86'AX>#@X.*BHJ"@H*,C(R0D)"5
ME96)B8F(B(B/CX^3DY.9F9F&AH:4E)2!@8& @("6EI:+BXN$A(2ZNKJAH:&^
MOKZKJZNHJ*BLK*R\O+REI:6@H*"SL[.NKJZBHJ*XN+BWM[>PL+"_O[^]O;VC
MHZ.IJ:FVMK:GIZ>YN;FQL;&JJJJDI*2UM;6OKZ^MK:V[N[NFIJ:RLK*TM+3!
MP<' P,#-S<W0T-#)R<G4U-3#P\/:VMK(R,C$Q,37U]?+R\O9V=G3T]/"PL+<
MW-S.SL[,S,S/S\_'Q\?=W=W*RLK?W]_2TM+8V-C5U=76UM;>WM[1T='%Q<7;
MV]O&QL;Y^?GW]_?\_/SO[^_P\/#U]?7X^/CQ\?']_?WS\_/V]O;IZ>G^_O[@
MX.#KZ^O[^_OZ^OKR\O+M[>WCX^/N[N[BXN+DY.3JZNKT]/3AX>'L[.SFYN;E
MY>7GY^?HZ.C___\(_P#_"1Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS(
ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!/@@M'LZ;-FSASZMS)LZ?/GT"#"AU*
MM*C1HTB3*EW*M*G3IU"C A47\R&H4,"":=W*M:O7KV##BAU+MJS9LVC3JEW+
MMJW;MW#CRIU+MZ[=NV1%C0I7M2$I87T#"QY,N+#APXBMCDL\L!1@QI C2YY,
MN3)C4^0B.[;,N;/GSZ!#-\2L^;'HTZA3JUZ]DC3DS:QCRYY-NS9"UXQAV][-
MN[?OR+@3Z_Y-O+CQXR6#(QZ.O+GSY] 7*C_,/+KUZ]A]3S=</;OW[^!#;_\O
MW#V\^?/H#8\G7#Z]^_?P4:X?W#Z^_?OX+\X77#^___\ &K1?8/T%:."!\0W8
M5X$(-NC@=PI6Q>"#%%;87(0Q36CAAASNAB%,&G8HXHBI??A2B"2FJ*)E)KJ$
MXHHPQGA8BRV]*..-.,)$(TLVYNCCCR;MN%*/0!9I)$="JD3DD4PV*5&2*2WI
MY)14WI;9:Z95J>663UZ96Y9<ABFFE:6-:>:9 T$Y4#GE%!0..>.8(] YZ R4
M#C@%B7,.05X*)"6:@':HSCKLM+.GFNP,<PH@Q RT3B"H"%(,.JD,0H@[_QA3
MB"#'#$1.*(.H\@X\HPRR2CR-@1GHJC^2(@ ( 8#_\8^:Y!@CCCF&R",0,LD,
MI PK_RS3BCRNH#//*53-6LP_I3!3###_O )+JJQ6"^0A &0;PCC)]'D1.['0
M(Y LB(1B##NS #8.+<VT(E B;?ZC2#K_(.-,*\_\4\\IU%KK[XU 9)NM*,MX
M:Q$TT QDSSWH)!--+8V.$XLTM@@$"#X"+;+G-,&XPLP_^80B$#6,D!)--2BG
MK/+*++?L\LLPQRSSS#37;//-..>L\\X\]^SSST '+?301!>M<C3*-#* P  X
MD@K&&5ES#4%[_H.-+=( 1D\JU( B$"UR_C-*9M5 XTRG^:0B$#JW+"/.VW#'
M+??<=-=M]]UXYZWWWGSW_^WWWX '+OC@A!=N^.&()Z[XXHS+_<\S!# -P%\&
M2_0.+H0TTRD^^ 232S:S6%,.*=#(HLT[NA"3BC/_R(./,KM <TH\]Y"BZ#8#
M[:+JO[QO&(8(D@,P BGJ8&2.*[;H JPPTOPCC2O4"+3-+M4(=(\MK\#S#S68
M$J,*[O]HLPLW!/W9^_GI%1!\MD%\5,\\'YF/OGFT"#%$]!N^(\\H81 ABDCG
M(,'Z - ^C["#'?';W?P,! J!B8%#QC" P [P/Y!D P$#+()DY+= [SQ"8+3@
M$"PD9X2P=20<84A !C>HP [^1Q@"@P2>+!0,R8E 5Q[1AP(&"  -ELF%#8H&
MT_]$9B%C! ]_'2G' B2W@!)DRX=8 F*#EL&T,6PH8)(CPT?*P #)F6 8#>@A
M"Z6(("H*[ AUJI )@H<$CT@C!-ER@!DD^(!]J ^*7R+C<ZJ6D6PP[1 6&@<(
M@G<"3&UD'"@0F "HD804*.$>*A#C#_5HG&H80021T,@9F"8)"[EC!>M#!$=4
MP30$P$\@\!@D'H730DK6AAPCR!8$^&$0>+2C'>-(XT*V$0&F36)#+%B?+C@B
M"X%)0!$%08,DH^A*XN1C ME:@O8*P@H*4* $2T@##A-BCF *3 WQHM )UF<*
MCBA"8!,0%T$"L<P\-I,X3,A6$PY""<FM@2%.8!H%GC#_S0>-,UL,J$"V>/&/
M=NB#CQ0)1@NRE0 EO*,@YR3"&-_Y&RAD*PH'0486%Z(, 4CN!(L1I\"DP(9L
MM0(=!+!  Z8PBXJ,06!46(=!D-&&1IB0E12M:+;:: Y4  (0Y#N%Y!XX$'[\
M]!4#(43PW&"A?P)@"6+(UBWP<0&FM5(A8<C6 $:1D&2$U)TYI<T47/""651A
MI_^@A\ J@8H#2.X-!"$E "0J$!ADZP!ER!8:**0,?,1 8!@HPM)((8T=CO2F
M#YF"5DN1$#6=A(-A18P,LG6!7@(@ [80QQ(!  A+!$\$:A,((K+%!E[TPA6;
MU0 [ 0 '@;2#+P%B!QH,4((-_P@L#HEXHARZR+15+L0>MBB%"[*E %\TMG+D
MN6ID06,-]06O$>@(0+9( ,?@S6 @1LA6 '@K,!H4(EM2,,4<'H "XP)H'QQ@
M&@-PP0ZA I2[V8J .AM23*8=H!['G>1R5R.,#*P/ C/H  ^S58.!Q'* CS"C
MY# @4_1PPPA&H$,W#J($IG4@,[L8, (:Q9!T*&&-3#. /O++S/VN1AEA'/"
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M=YJK]Z@JTS#Q#PD X-8)0;7D++ L$H/5UZ%!A:<Q(!!Z%('/&-B'0"PJ.1W
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M]M8I,XL4,"T,.Y"<T[60K6$0!(M+N#@ 7! /+O @"E8?"-TE)X&'GF<3/!S
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M:W8;@2 #4DE8)EX=^L2&0Z[);MB,1[ZHE7P':E&.@0C.SQKPDAV"IW6":0Z
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M@A$/1)P9\P,//GB ('/X1RH( H=_".,;/R (#TZRB.+]XAO"@*%#^&$$&;"
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M!WTC""?H5^OM-UZZ SP0@R(0!BR@H"&M359@!%UXNAVH!WA0AD9HKH'X@ !
M 7,E#GEHA59@!85X@X%  Z#*AMV27_S8AOH-V(+@&?Z]7HQX!19  6)X!"IP
MV,^-LW3@E*4(B0AX%.94#V_8@^,!@%Y(("("@$D *G:@P1&^#V]H7(50SI51
MX17&B)3[AWM8G\9RA2>0TX)P@,-$C6OX@STKB!28!0($ /]+""K(B<GG1986
MH 8K@ +O(8A,B&*SQ-Y_P 9/6 -<\%P:5@A[F+8M+@@NN.+<P(7YT@HT4-%'
M"*I9D(1>L&#BX ?P\ $=A(J?JF,UY"5D6 (F$((8X ,%Y=6$( :,6HH#L(-G
M78H'T $9&X@7Z(-KL U>.!D!V"  V)=,E@AWV),4L(8E6@I,UN7NQ%X[ -E_
MX 8>*&##V 59Q@=*T(HO^ >1Z@P?T(=\D*J" $M9&8H^<.63H>-A5CQ.*8%E
MJ*6E. -Q)F:,2 0FT 1%" ,NH(_<"+-0>(&*'0@EN 5V((*!T  UV 8YB0?6
M#%8 R):&< =GH(8M2()&Z-J7  ?_B?JA$O6]'X)+=7:(> "A :@$0!4!-> $
MSL3H5.,E<_"$'X"!)HBWW.B$+=4*!RBC7<B "L@!ATB"BG:!AO"$!5  &UWF
MDQ '<  '=HC/@C@!?S@%?TSJ@E@ C!SIA5 'SC#H*0* ='[J: LN?>@'40Z,
MY3.1.& "*?#%A."'?)BMAH@';NCG@: !4@ $0%B?:-#A@J  7WB)."B  F"&
M9Y#C8)P+.P #O=F#$B6 0KYJ3:3F+A#CKSEL.5LA9V"")@""*= "(H@"+]8+
MS2H()5E9C"AJ(.""@>B&?PAD@G" .V:(>N@;-"B":=& 31B&Q5P(.^B.QE8(
M=J!'@B "_]MV[&^%!C=0 S'  SZP@S"H7M30[!I\:)2(4P! @-WZP<VYK2RP
M!5MP4X@(!U!ZR:6(UH?(AZ(I,MY.B(I<BAX(9_'6+UYR+7982>0VZI@ !D$F
M"$;8Y0B"@GJ8 ZTXSX<P&.@4[Z<HB"TP;/0^KA5BAU"P 1:\!"@0A=U8O@>8
M 2."B4N4;P!@@_T%!UP$ !20TH+(!8F@0;L6[S98BLP@\ U;H6& @2GH$6YP
M B7(4<  !!+P %25"7OHJ7RI@',>" 6PVX7PZGQ!F(B AE$8A>-N[+$B"(PY
M\?3^5E;P@/.\A!Z(9+W8!6B0![4]"7!0)JWH 50 \U) 6282Z?^%((8G,.6E
MT(*\'0@L@,<FEXC2WDPXSZ\5\@8>F(-GT =AJ((@:.]*)56=T,P >+H+4(,&
M5XA;'@@&N(2&: <-API B :CH?,X7XH-KG3?0J-=B $8\($=Z *%?"B=8/-1
M  3W:0A#6(J?3 AP. 0]L%&M^(3X'@B,R_2'B(6*QO1;)RQ>\@9%6 19Z-)1
MGXF* @!2: ?E*H#?*8<KR /6>H)Q DQ1O8Q@@%\ 4(#KYG6%X ;()(A=WW:@
M"B[U -VZ>(,WR 9TL)  F.=M&8AHEUZ": %M4&45^(<8!8 IX-U*+X9@!?=P
M+ZAQQQ_EA8ER +L&0'*%H"$ 0-:$J ?_!!T(*X"V<"B%5J",7/ #+.@M@%<(
M;P#F@?AWCM<E@9<7@G\)=,"&8OAIA7A%"U<(52\(%C!%D5^(>N!Q  AYFC<C
MDA^.<A>*HFX A?N'4AG(6$!MD5\'4AN(S=/Y8^+YW?!YGGA7,^2/%YN"9VQZ
MC#@'? 0 $\]Z.7KZAD@'76B>=_"%0IB%TP"&0I"%J^"&0@B%ZC6'42@$46 '
M=F"%0G %ZXGZG0"&N88*EOEZB7@'.S*+5,#LP1>>L%^(8\ %3H@78> %?+B%
M8N@'Q.,%6(B'4I"'89"%<$F&9(B'6&@';\@%?+"%E>[[G1 EJ&" @U9\B%@'
ML , 3XO],6+\_S)[AD2P'E(8$VVHA6[ ,'H@!>!/"$+ I5@0(61(!E!0N'J@
M!85P!5&W#7@P5=?OT]M?B&'P=L_2?AEBPYU8U'](!/C)AE\P!8I;A8M+B$4P
MGT[HN%=PA9 ;.6NHA%$8!L?3__WG__[W__\'"&C&4@ H:% !AE##H#%LZ/ A
MQ(@2)U*L:/$BQHP:-W*\.*S:@X)2A$GK:/(DRI0J5[)LZ9*E,%GX_M&L:?,F
MSIOH.H&K66K?/V:OD$'[1TX7-E T3X6CV2O>OVC$8#W[-T\5376KC,4[Y_4K
MV+!BQY(=6Z[?"8,%0\0+U[4LW+ARY]*M:_<NWKQZX>H+"8"(N[V"!_\3+FSX
M,.+$BLFV.I?S,62:Z!#U?/=.V:]^I?+1V[6O%;1PJMI] \5.'3QHO/C)TC?/
M53]7V6JJDA;Y-N[<IG@8,9@E-_#@PH<3+V[\./+<[T)4$# N.?3HTJ=3KV[]
M^G%8Y*2S"_;N'[1K[$01ZD83&J%6WZF%*@55F3]QK10)H]F-D"AV/NMC!PXN
MFD&\]#<@@04:F!L[_.1CSX$-.O@@A!$B9\IVU3VSS76E\"<A3<88% R'(8HX
M(HDEFG@BBL)1:)UE&6[(H3(0%"1@BC7:>"...>IXXXH[_J,AB=888TR%/AIY
M))))*KEDCSL"N22444HY)955XM:DCD]:N27_EUUZ^66$6.:H)9AEFGDFFFGB
M)":.9*KY)IQQRKDCFS>Z.2>>>>JY)X%UVG@GGX$*.BBAD/E9(Z"%*KHHHW >
MFF*BC4HZ*:53/HIBI)5JNBFG-5YZ8J:=BCHJJ0=^:F*HI:JZ*JO'G5IBJJW*
M.BNM-KU*8JRUZKKKJ+>.F"NOP0K;J*\B CLLLLGN66R(QRK[++1I,LNAL]%:
M>^V6TTI8+;;=>INDMA%R^RVYY=H8+H3CFKLNNR&B^Z"Z[<H[;X'O.A@OO?GJ
M*YV]#>*[+\ !JUADEB\*?##"_!(\IL$)._SPP$;^"S'%^O9[X,05:]SNQ09F
MO#'(Y'9<X,<AFWSM_\@$EGPRR\JF/.#*+<L<[,O]Q3PSSK36C-W-.?N\ZLXN
M_CRTN4%;US/126MJ='5(*_TTL0M3IX\]]:3SCSC\E%-3/POCPP\Z-,%CCSDV
M.0TUVH3N;$\DM*"BS3NEA(()/_^8H@@@U]3D#B&A] )..*?$DH@\^Z5]N+ [
M?V/,=_]< \L_S?QRCR__N!-+XZQ4Y4LVPTSS3VDU[5(4XJ77NC,IEL0"RSNY
MU#=.+]?,0E,A6_\SR-7( ).+-__4@PM-XI!"##S%&W\\\LDKOSSSS3O_//31
M2S\]]=5;?SWVV6N_/??=>_\]^.&+'STH4DM'S];(?,-+-4;A(DWE_V RT_\_
M@$ U33"V,./[*C11PP@IHE&- 1*P@ 8\( (3J, %,K"!#GP@!",HP0E2L((6
MO" &,ZC!#7*P@Q[\( @;2 Q2T,\Z_@B;-E+1C&58+A?M4 H[9-&3?ZBB<,C@
M1C>P\8]MS(XFHS,=$&6ULV3H8AJ_L$<X2 &,6'A#'+8PQ2T^UX]S/*,7P<!%
M.>AQ"F>$8AZ&"R(82Q4T;-2B;O_X3#%H<@Y>$$,_G(D<*_I!$VNTHG=?#",>
M.<4TZIPMCW[,EOG^U+ _$E)M@434( NIR&4=$E*)7"0DY;3'Z?0QDI;,T22E
M4\E+<C)%F8S.)CLI2A)]$CJA'"4J)53*Y)PRE:[_;- JD=/*5])R0+$\SBQK
MJ<OJW-(XN=PE,*'3R^+\,IC&+,XPB5/,8S(3.,D<SC*;*4U#-1)3CYPF-B'T
M3.%$,YO>W&9PNNE-;((3..(<IS3+F9MSHI.9ZL0-.]MIS'?>)I[R!"8](V//
M>^HRGY#9)S]IZ<_' #2@KAQH3@IJ4%0B%"<*7:@H&WJ3AT*4DQ(UVS4KJE'=
M5!-4&=TH2!]ST3N&M*17ZBBJ/FI2DXZ4)A1=Z1];^B.5PA2D,GUI3?%X4YKF
MM*([[2E0[8926/$TJ ']J5%KBM2DKO26TD@$*LSX#W7((A&\8 <Z9I$(593-
MI45E:CMC*8]2D*,8I C;_S^<,8URG,(:QVA%.%*1#)*"U:9#I8XT:D&30:B#
M)JO(G3% 495ZT*(FNFA&74WZBN<\B!BVH,DBZ-<)QWSC%:[87SY"09-V9*(2
MN/@L:$$;BT*$MK2X((0B3!M:TJH6M(6(16MQ@8I!Q!87H4A$;1,1BMH.(K6Q
M96UK"4&(VLZVMH5816QO6]M5 %>U@T!%;5%KW-HJ8KBQ+6YL$X'<UBHWMJ/E
MK6];6UWCPE:\M$TN;K.[V]:N(KVM_6YLI1M;19RWM:^];GU5V]W6#F*]JF5N
M;7'17-,*E[CY->UQT;O<YH;"$B5L4#.4\@^FT(064%E&-:AB%5W0Q!S)* 8]
M[O^QCA&OPQWN6$<]7#$.?9!XQ"Q>!S"6$>(6FW@=_="%/%Y,8Q:[@A_R:/&(
MY7$/:?""'B<&LCS<H8Q<C./()+['CUFA#2$C^<2FF :02_QC?HS"'UE.,HR!
MD>5UY'@=RV#%F.]A9%W48\8MU@<]N-&*%6?9'?1XABWHC&1]L((;;G[S.+I!
MC#^/6,WR<(4^=$QB.R_#&(0>L9VS4601MQC*X\@%-10-:7IX8Q:/7H>:[>&+
M3^MC',$0AJ9;G(Q7C)G$HYA'J]=!#%#$>AW-2$6:Z4&/5&1C'?J@M(O'\0Q=
M@%K3I=Y'*8I=:7J8NAN^=G*+\=?D5JO"QZU6S;3'G$+_/6<Y%]> =HNWL8L:
MCWD?HW 'L('L#&"D^M?K$ 8L"'V/%]LB'S]^LXB;48MLDU@?)WY&*OA]5^K@
M0Q7/,,95RP&.O.:#%/*PARZNHHT9XB,?^H",/>8A#IUTN!WW@$P_Y@&/G%S-
M'?6PG4WZ^H]V2-4FY@A;/KR($ZBDXXTW43EDFI+SVW0U,NM@!SOF00^<O./C
MXYB'?G#BCW_$0^0XH4=?]R%'G(RM'_Y@[$W<88]U  4GZ+#'/OQQ\9SP8Q\C
MS@D^YK$-C>>D'_G8ACL><X]Z4&/I1+>'-=J!<A-QO29H]?L\2IATF\RC2'^G
M"3GF@=;!XX1JD'G'/*#R&'K(__PQYZA\B?YNC:[;).GRL!K'-\N@FPR^'ICG
MD#5BH8N98..$H% (39"!"F.<XQ/_\,<@*A$)%M:$%JP G2<:$0J[_P,<D&"'
M/D)1B4=T8_"_&,4_A!&(1B0"\^;0Q"^DT8A&(((;-L$&)/(1B\[B@F#UX,0Q
M5)$)ZA/_1XF@1B26#Z*:B*,-DIC%/?9.DUS,@1;:&/M-P($GV((_7 U.F,$F
MC (_.,9-@,,W!,(L_ (D?,+GU$0^T((E5(,D-$(GQ%U-^(,N> (R8$(C6 +F
M78,F] (P. (DI,+&U40[K$(E: $=K($KV 0Z.,,B;((0F,$=U(--\$,O/$(6
M9($=]/_"3>A#*2 "&$Q!'0!"X_P#.Y1"(U0")42"(,P?36Q#)'B"%2["\-G$
M.AS"(S0")4P"(6!(301#)CP")5 ")OP"XW5%H?F#/XP<3;P#.<B#/XC8U=E$
M.IQ#'?K##-%$.9R#B-V#'>(<.\2"&$2"P_T#(TS=/^2#'33"(7S#/PQ#)]C$
M/6Q")EC"*P0=)=@$+X1!(Z3A/P@",=@$.(1"+#0#)3A"+^@<333#)21#*CA"
M(R"6W]$"(6@#(C2"(DA>3=@"(#1#)W"@!_[#.UP"(&!")X"!'@Q"(?X#(4Q"
M(2P"&;!!)Q3)-E "(73"(A !)=!(A5U"(72"'1R!)GQ<353_PCZH@RI4X2S8
MXC!<PC\\@R$TPB4<@TT@PC&\PR]40B.X@@'2CB:*0AG20N'XB#Z4P3\\@M[\
M R?H$$T(0KQ! DU<@R/41#BDP3]HPES]0R.T#TV0PBZ(@QEL5DO61#(TPC_
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MG#L(M4_70AK5!#3P]%KS;38X@RBL=3.&PRLD-2C -#($ZE/O-4QC;ST  S
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MBIX9-E$)3T""?X4H!#G$H<N-N (2A]#$(H*9CXWP(Q$P(,0J;A&'CR6$&F^
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M#&;A=%TA#7Q1'20!&"YA#R[AU'2VV-@B'^01/,0 &>KA&2XA$@#M'\)2%]9
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M(=PV8A3JP&+*@0S.2 WT=!W:81Z@P1Y@(1+!81MP@0^&X!;X!WXG@1'D+A-
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M@1U,X1$F(12F@,7;HA;N(!O&P1UP 1+(["QBX8L(HART;Q : 0X0?2W:(0R
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GY<R;.W\./;KTZ=2K6[^./;OV[=R[>_\./KSX\>3+FS^//OWV@  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.gif
M1TE&.#=A00([ 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M8,!,RVWGLZ<SW>8U;P-^D/+3)!4E9/](7?IN][LGN\L)V  >OK :@JV\).Y
M! ,<\/B(-+SP[ES Q/O\[PP\P.TZEXF]$7&'R$>][)BO9]K[W("3$_XT3&?)
M'>2^"$5(X_09F7KJKRE6/^]YV[=M3==-@@]I+$(:B"@MOINY>W0N(!%[3@ >
M"D& 1( >-2J%B03$;()VA$34S1>?_]L70'[8P OK7WC HU_S]Y4H(A&)]@CX
MPZ^[ 12"B:BQ ![P )L*J/L _"<;CG<3#, &A?!RUT=_LS-S!_ #I\%O155I
M7Y"  )!V&Y!FL]%^*C$!;(![W&%V"I@[1I=K,94!&5!>436!K*%Y[+8!A4"!
MJ!%[*I$7BL  Y.81NA>"K)-G6/<#%M  Z\9G)S<_:88'V>:""T"$JS%\(P%:
M<( (3^AI'L@?(*B#K!, 7'9>&Y !6&=4#KB" ,!Y)T<;V<<2\6 "#* /#("&
MIF$0J!$ *5,\LC9P7 4N=6>%GC, (R"&77@ (_""K'%UYW5SKR=\<Z<3$C!Y
M$* ([D!Y_O_0:A&#5FA25VEE58.'A[HS FK'>>=U "J8&H5P='VF=+,Q@+WC
M#HIP)0ER#HD *E%V%Z!B !"R9)5U>9A8.OP& %V(>'Y%B*F1;MEV5%^@A(88
M*R9 >7'"6OP#6Q"   "4C-MTBYX#+S_@ 3K%B7TV GO6=K_H 5WF;K4A@RJQ
M?7>@ >MU!Q0"  =87Q2@(1+0)*%2(:+R)OTU)P=6"/V )P,  ?V C_K(C_X(
M ?O8C_DHD !9D ,9D F)D ?YCP3ID K9D ;YD!,9D12YD!#)D!<ID1A9D1II
MD2#YD2*9D23ID279D2C)D2JYD2P9DB>YDBYIDC*9DBTYDC,)DS;_29,QJ9,Y
MB9,O69/Z^((@0')^EG>=B >-H XXMX]*5 A[>%X9  "Y!0$%1)5X<G%6297]
M &\RX0!LD'QP8'QPH!^YLBG\$&<IXEA04@%3%AI+TB"V*(V0(W*=Z(<HR&<;
MX %?8'*J\0U&R&?6=QOQTI4F@"UWX ]W "4+0 $.0 %)"%>\(HEN]@"2& ^I
MY0 (0&<?)Y=EDPA(]!J:A75'56HVMVV)\)06H#Q UGJ :!M,2!(3$'?UH %P
M0 "( "IUR&@"@6B[62'Q=UC%PIEPHUG:F)JM\0"%<)<-R&]&V ">]PUIQW8*
M,X(^B!NF"&8VZ'-IHWP=,7_"634/0 ] _^@,UT</JW>4G_<-)P@/R!E]'M!O
MJ)%VGI<;&G@2B%9HWB=X=_B=5.,!YS4"Y*D:FJ>%I:DP_>8=$*")#9@!SI!F
MWZ")\WD;XI@2S59D13:%\S)?_&DVQF94($!XYUF:KQ>>?99XA;!/&^ ([A9\
MKGF(+6$"TK"&)F "B;!\@K:A5M-OD\9G$9IFSG"-?C8"BU>(NMAEC(<'466<
M$@HU,2$!A4D2+(6C5 ,!]-"%[E9^Y&4'G)< /\!O+/J+NLAYA:!GE1:@N/&:
M(^$ /M<!=[ (&%H10B>E/#-SV98 ;/<%>. !%F !6,=NCM"EL/&4)FIT4$FD
ML%&&+>$.=["HB_\:>!B1@W+*,Z?)B5OHA:;69S^P9QE @>0EI@"PAPT CF?J
MHC.(1/#@F?  #_D)%LP7J4RC674IA!F EUTX A;P!0('&UN6:U"%!U7J5Y]H
M&Q-J$A*P" S0 Y\&=2_GJDU#HB7JA_[)>1M #R]8 8;Z@.*I:Z#ZGKJ!IB#Q
M.J\3%_;EJ!?AG<PJ,]AF5-;XK+K6FK*!A5TV D>'<[J!J"TA%VM"KN6ZG^?*
M,D:XA0 PJUNJA86P?K&QJYW(;A8'@^Q'JBM1#[6Y"%_YIA2QF?VJ,M\ JW[(
M;[/:9=IF&PN0K7U(K\S"I# QH_:F /?V$9!ZL2J#:WZ(<C![;.<EJK/_D6<F
M*+!010]%UZT%AQ)JR@9P=8-TT:HN.S.E%@(IZGGI1K/:=JVLT6\64*(]BAOV
MRA+U("J<\GW\>K07,[50)0\K.JE\IFQ\MJ*W(7)ZMVV[49\F 0$$\ TB8:Y>
M^R\9BW)W*[-U.I];!E7.F79CB!M;5I=5*ZPF^Q*)(+':H'!<R[!U:R^XNJ=[
MRG@5:','0)X<ZV<9D'9?*+A96*A?ZIH_>Q(3@ @*  [U<'O+1XR/BR\C<&HA
MP%D6  %". *;N@#^ (Q&E0&XUKFVD;$">P AL*F[<;4J80*E]2)P,"TL>TRM
M*S /  %8!U4)X)Q(ZIR?AQH/L)<'T A?4 BS_QLX8&M4;-NM#JL2A8 (R6H7
MR^=,S_LO^O>4G!<"> "JY8L:#]IZ* >U8>4,G%>XX7BX,&%?&L*U[RLP"NJT
MB5>VW^!V&Q "@;L;FD>].^6XKN&M'Q$]D+DKN+*L!PPP/^ (K!>K9_MZ&[!N
MOE$!4RNBQ5MY#/=IG>9I!TAW'_POT?J?/R"D@KH!P9H:)T@/OA&>[.!76_@
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MBG)U.-E8=5CZF@AI!6N[8L;],LTNJPB6C(TWE]P _S*"?%9Q6O+7!6&#O (
MDH?>4"AYGG)O#."F"D$!FY:LRMJ\Q)W&FCVPA2H@Y1=6FWN-U0B 6I+$3X<(
MI\$&9<P&QGH';* !4,;>C*L0BC#6=S  BJ  W,FJ4)QS.TK"?AC']E$(SI"K
MKS&S";"IE)O;AZM_^]?B+AX ^N!S=@$'- H'4#+,P%-D3\H0R/L3:DJQ$\';
M_>H,>OT _HN-"]S=_['&"]H:FG=J4'6E6_(SS0F$5MX =O # 0"C*AL!1@8
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MP %'4ZUZL*#3YH)"4QN,V&ER0862$"P4PB/T1U.M;=VJ)*" (AH^=>W:S1/
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MD(Y5\ZK;+QH!\X=X-\L@A 3 8M>KEKV>[2J9;<)C ]*B6CPLOC_KU6Z[36#
M'1,BD&9H\292^/3%[(S(Z,U?ASTTK@!OA$NK-&V\ 3$W>Z"0=D?(,O(#6C8N
M@ S Q6U?F0Q,%S>K'H^=LX ]=UN!11*Y0QN-)@*   <D6* ="1R0JU 'HO7>
M@406B."<"("<.'KYY[_I@40\0%X>;FMK@)X ,M[ Y-XB(-JP!@\ARP ]/" J
MDOQ 8PY*Q,U>4@@+K*\DH)H*!.GW%O^=4<]M0$H6]R00  )$H(0/8$ AW#&9
M"40$ !+P!P$D$# 'A&A(FME@#G6XD@QL+8,; !76B.,3//Q >9U9 #U^@ =X
M/(!37'/@"!(1EI6IQ@-I>PFW1J"\_2'O!SO4B9SHY$&> < !)D CW3@"@7H4
M@@*%.9\#&B;'.08  A+H$7H4\T(BD00>))$, /XX&3\"LI"$%*0A$XG(00:R
MD8=TI"(?N<A(,E*2E[1D)BNY24AVDI*>G&0H,<G)3Y92E)H$Y2A3B4I3D@1!
MA7@ER?J!AY-Y92G'N]T&"" 6DR"H'XT!P"]]"4QA!M.5QQPD27@"S %9C6LC
MJ5R40/650 [_  #6Q.8U73FOKRP 9EZA)C#%23)R'E.; #A*/Q)A3<G \BCM
M_,8[T1E/0KJSGO2$ISSMF<][ZA.?\_1G0._9/1B1,6(U"II!3$="!MSQ"P%P
M1Z'J6,=^2( ?RY' 'NO!@%]*QJ.$_&A(03I2D9:4I"<U:4I1NE*5MI2E+W5I
M3&$Z4YG6E*8WC:E1U+G31/1C 6<32F[@L8!O'/  M4M;/P9 SP$,  )'@4<A
M!I"(J$ZUJE25*E5[6HBG]D.JDVDJ.W=2J]L5"$J.6&#4OA#,GK:5ITK]!@8)
M,""B%+$X3=UJ5[E:"*_JE:M@A8=7C2F9G1*RL(3MJ6$3B]B.LK6Q_X=UK&(?
MN]C(,E:RACU*"0W*,S1^! #+*:$"T!" "=PQ -]H8</<84<)Q$,Q&6T= W (
M1MJJ[:<;^&)*@HA;(_KD4KCY(K^.$\10]2Z#3=+8 0ZWDJ_=Y@ >2-,&OB'<
MVL8D'@7=;)"P-P%W# 1A *! /21 DN_)D0#=!2T)!_+:>C@ ?GVL;GPMIH@%
M=&P#ZS/7:[YP-3 5AV0[2<35I$A=V3FP-BU[8@*<L=\,"G G#V!+ (P:N"VM
M57/RK<D7L)M=^+CC6=HI!$<*L0 71NLH+HR(9$H\$==AV,78>H #L^:,!%J
M25VZL#('-.)JU:>^CG N$&^3@'T-&0_DLO] 4909X' -\<4WZ1R'@X2!P#Q
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MB4P@.X@8%!EOF'?"_P0 SIS*#X;\ W@XD"@&KY3+&Z&I?N$R@\<6>)1&7'A
M8ISOQZI'1A#Q<;N%G/.$]_8#&_&%;X(%#XU ^<6< 0(+HV1I5GF\!6XC_[+3
M=R_PGX](QU-L+(,&O?<C7WIR:TU W?$$[TA[#;\*08\&.4[E(&LVX;<.?/G
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M QY_^>7(:'_Q]=<&AM%U& !!:4409)\M]1D:?92DG79'9?12!;1]]H S"32
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MK+H@)+D(8*\=BWW08B%  +MIY:8A_(*_TH$/"GC!#_(8P5WT1,(&- )0HLW
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M"H=&%E=9ST9K/=CL\6%QF7HQY)IO!"# EQ9< .3O"CK?YW[9$]<#!$Q "A,
M!BC &_:#]'*%]D8 (DC &W*%]%( (E  E?GQE!UR(O>L])K ":]OSDJ#"3#
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M&E\;JNP54P#8ENL#X/]#L,4)5P3YD(>W5D0CV#(LNK 7PXK@/'<%E$L.NE(
M;(XK"?ZW3 1ML'V*9?^W>/4L!;!7N1+ F&N%@P> ^Z8KVDI #'8'[Q9""1+
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MP0D4B$"!WABXHT$)3$LD@K__;K&C1:1IS 0V">A @;J!S'MOKOT&/ +!59H
M#A,P8"#LQ!>/P,<O$"F)T(+XD3P"Z[9:!!'#)]7 G<4!)>@.$_9VR/1"9T)$
M'\P+I>".R2.8;Z"9!G1 >-,C:/^.8CAVWS:A//$A(())%]%: C;_IN!O!9J3
M )'J&_/Q@0XDD)YZZS\TP'2["(+@#CC2HGW#PTN73@*4XEP. .2Y#L !.&:7
M%NG HRF,T\XB)A"G'4D/</SPT?\TH(_,7:8@FJO;W?REMP9Q;7\1T)[=$D(
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MU998-XC$10+]&&S[<J:!8ZFD,98VM/0^[! 3+-L?V8Y66B; /G>88&5;RRS
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M^/<.!2Y(OMA-%*,GWE5;@?U2HU1OF%.'RR<#FK623A'27K&ZC0+Z*K]P<HH
M0.M[+Q%%8!U++[)<T=9*1#P*L6*#:'LLA9].72M(()\/)!']8.(7IJP2\BM2
M.>@/B84(L*K;,Y&)[%79MA !.0H" =JJLRCG<#0/'A2,359B:DH),^#A#GS*
M.#0 4!"P??KA"_CO4[1E GR"3X8NG'Q/\_\@  T4<(D69A%<#T8(Y,L>XLM6
MJ/^^8069Y5B:(C,(0$^DR2L\A8E,D  "CB>.)8DR(U&6@ILNJ?0,P@>OA>I8
M1C):!4.0L+_N0$D6  *^(1XZKSD>YECH3U<HXNL$ TK2CHF>KLD 4#-<T/=2
M98A6CON(B2\RI]F6@P!6QQ_P 5ANRNST1+?\)X9V![]6YP'R,#/<X4. 2^D\
MRG DHD*:HDLR(QXF(#O\4 %"I2:N*',<;G@0P3&\K4-VI!*'Q!\H*:(DXLNL
MS+0:0F!V0^GN #:XPG 8H.8(PAU")P!,X)DX$"P<)4[ PG :XT-L<3%, +X2
MPF>$1P/(0T\:!?#_)F"3(& 1?$A@6L5!9D4P/D0"(BHM=H0!_@P7E:,K:A%*
M:*L0YI"7X"T 1,A 8 5.V$1/0([*VBF&<N0!!LPIO&3I/B3:<#$>!! .X9"A
M"N:[B$HS!/*FQLGS J"(I.X.@K!5AN0;"K)]SJT=#& "] $.Q&\S^D0BAJY-
M=JXPO(G)4L/^Z E81- @"*"WW,(S=E =O017MFX"0N<-54*0#K(A.J Y($#;
M:M(S)@VM,L,!!@H %$#J%N$,-0.@*DI74- ;)XPSAJ@U%D )ER1V!N!(I'&[
M>"1'7E(A%-)=,I(  ,9(AF11C!$@ 3("E.XM9JXL)X+A/(I/*JLZ(F "_VR2
MGD@M)[6C+IT0FU91+M>O(21 'R;0=L8I,,\FKN)RE;SF:31#<YRE+2U+AA8"
M0#Z#+9O%+S?$_-H'0CJCX%8FYL!2 W+-((Z2*P>%X6"MQZ#N7=# 0SZ#96 -
M,-DR4O:G'O)R49Z%UN"28NS$(F73)?=R^]12T0A -6VC;HP3 (PS/S@-U?CD
M.6WC ?XF_E8Q+SG#.LVJ(?J!.FV#@30C OY1/SJ(*PD@R,A$>F:J?;"33/K!
M@X2I/?6#TRC@/M! .3^#.94#/#\C.K7S. 5T0 FT0 WT0!$T015T01FT01WT
M02$T0B5T0BFT0BWT0C$T0S5T0SFT0SWT0T&TY?_ 2QIGZMY"]$11-$55=$4O
ME %ZX$5?-"6L!2$BH ?@;"$"E$5U=$=YM$=]M#-,H ?>2P)Z  [\!P[8@ TV
MXD4702I>U 1^Z4>E=$JIM$I7= )Z("6TH0<"8 AM] MLM$MZ !^"5 ^M]$S1
M-$W5%$%=%"G8@$O1 !'@H >BJ@?\9$[A8$OS<4WYM$_]]$^'Q45K[PYZ8"A>
M]!EL-!%ZP"<(50(H@.X -5(E=5(IE3."%$:E 1X>JTA[@ T*84MG#TF+5#\K
MM51-]51]-'*FIS7:(7@ZKP*RTBY:E3Y1M59M]59Q-5=U=5=YM5=]]5>!-5B%
5=5B)M5B-]5B1-5F5=5D$3S4@   [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
